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ABSTRACT 
 The body’s master clock lies at the base of the hypothalamus immediately above the optic 
chiasm. Because of the intimate connection to the optic chiasm, this hypothalamic nucleus was named 
the suprachiasmatic nucleus (SCN). Environmental light signaling conveys time of day and seasonal 
changes to the SCN via the retinohypothalamic tract (RHT). The SCN then relays this information to the 
brain and the rest of the body through synaptic signaling and indirectly through circadian regulation of 
hormonal signaling. The SCN is unique in that in the absence of external signaling, circadian rhythms will 
persist. This is accomplished through a transcription-translation feedback loop consisting of both 
positive and negative transcription factors. The interactions of the players within this loop create a near 
24 hour rhythm.  
Although research within the SCN has focused primarily on neuronal signaling astrocytes 
comprise nearly a third of the total number of cells within the nucleus based on stereological analysis. 
Moreover, the astrocyte cytoskeletal marker, glial fibrillary acidic protein (GFAP), is expressed in much 
higher levels compared to other local hypothalamic regions containing neuronal fibers. GFAP allows for 
the rough estimation of the overall astrocyte cell shape and despite a lack of in vivo polymerization 
dynamics, in vitro GFAP filaments have been shown to be dynamically regulated by phosphorylation by 
known kinases. Additionally, the synaptic signals encoding light information, glutamate and pituitary 
adenylate cyclase activating peptide (PACAP), have been shown to bind to receptors that activate 
kinases responsible for GFAP phosphorylation. 
Based on this work, we hypothesized that the RHT regulates astrocytic cytoskeletal dynamics 
within the SCN of the male rat. To show this we established that GFAP immunofluorescence is 
significantly different between early day and early night within the SCN. We then showed that this 
observable difference is likely due to a shift in GFAP polymerization state from filaments into soluble 
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monomers. Second, we clearly show that this polymerization shift is regulated by the optic nerve and 
not a circadian phenomenon. We further establish that long term enucleation decreases the overall 
GFAP levels relative to other local hypothalamic regions, suggesting that the higher levels of GFAP within 
the SCN is regulated by the optic nerve. Lastly, in order to establish a model system to study effects RHT 
signals have on SCN astrocytes we characterized the polymerization state of GFAP within the brain slice. 
Moreover, we studied the effects of glutamate and PACAP on the brain slice. In conclusion, we have 
determined that signals from the RHT drive the observed levels of GFAP as well as the polymerization 
state of the GFAP cytoskeleton in the adult male rat SCN.  
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CHAPTER ONE 
 
INTRODUCTION 
 
1.1 Circadian rhythms synchronize internal physiology to external cues 
 Life has evolved through the optimization and synchronization between the external 
environment and internal physiological process. Light has been a consistent environmental cue that 
serves as a daily oscillation that organisms used to predict availability to food and mates, avoid 
predation, coordinate arousal or sleep states, and anticipate daily physiological stress. Optimal 
physiology can be anticipated and prepared for by varying brain activity and hormonal release that play 
roles in arousal, hunger, body temperature, blood pressure, and others. This integration and 
synchronization of internal rhythms to environmental cues is conserved from single cells to complex 
organisms, emphasizing the importance of circadian rhythms.[72] 
1.2 The master clock is in the Suprachiasmatic Nucleus 
 In the absence of light, organisms continue to exhibit behavioral rhythms in a near 24-hour 
cycle. The anatomical origin of biological rhythms in mammals resides within a small, bilateral nucleus 
found immediately dorsal to the optic chiasm within the anterior hypothalamus. This master clock is 
named the suprachiasmatic nucleus (SCN) and was located through electrical ablation and resultant loss 
of behavioral rhythms in rodents.[67,109] Spontaneous circadian membrane excitability and activity that 
continues in the absence of a zeitgeber, German for “time giver,” is a unique property of the SCN.[47] This 
network circadian rhythm within the SCN arises from the interplay between three cellular oscillators; 
redox/metabolic state of the system, spontaneous membrane excitability of neurons within the circuit, 
and a molecular transcriptional-translational feedback loop (TTFL) found in neuronal cells of the SCN.[164] 
These oscillators allow cells within the SCN to synchronize and create a coherent rhythm capable of 
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output to local targets within the brain. Moreover, each oscillation has the ability to influence the 
rhythms of the other two.[6,164]  
Redox state, membrane excitability, and gene oscillations are not independent. As one changes, 
the states of the other two shift to stay in phase. The oscillatory cells within the SCN are reduced during 
the day and oxidized at night.[42] Moreover, Wang et al. showed that the redox state of the SCN could be 
shifted by adding either an oxidizing or reducing agent and subsequently, peak membrane excitability is 
shifted.[164] The availability of redox-sensitive cofactors that membrane channels and transcription 
factors require for activation allows redox state to affect neuronal activity state and gene expression. 
Spontaneous membrane activity in acute SCN brain slices was first observed in 1982 by Green 
and Gillette, and Groos et al.[47,49] The peak of spontaneous firing occurs around circadian time 7 (CT), 
which corresponds to 7 hours after lights have been turned on. This predictable and reproducible output 
signal of SCN activity has been used to characterize input and signaling mechanisms.[25,41,131,154,155] 
The core TTFL is a molecular oscillator comprised of positive and negative transcription 
elements. The positive elements, CLOCK and BMAL, and negative transcription elements, PERIOD and 
CRYPTOCHROME (PER and CRY), regulate gene expression in a near 24-hour period. CLOCK and BMAL 
proteins bind to ebox transcription elements within Per and Cry genes resulting in increased 
transcription. PER and CRY proteins are post-translationally modified and heterodimerize within the 
cytoplasm and are subsequently transported back into the nucleus where they inhibit CLOCK and BMAL 
binding of promoter elements. This results in a decrease in Per and Cry transcription. This positive-
negative transcriptional dance creates the genetic circadian temporal loop (Figure 1.1).[168] 
At the tissue level, the SCN cytoarchitecture is commonly defined by the peptides expressed by 
neurons within a distinct region. Based on this criterion, we differentiate the SCN into a ventrolateral 
“core” and a dorsomedial “shell”.[6] The “core” receives input from the retina directly (via the 
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retinohypothalamic tract, or RHT) and indirectly (via the geniculohypothalamic tract, or GHT).[125] This 
region expresses vasoactive intestinal peptide (VIP), gastrin releasing peptide (GRP), and SAAS.[5]  It is 
responsible for light signaling integration and intra-SCN synchronization, which is important for a 
coherent circadian rhythm.[6] The “shell” expresses arginine vasopressin (AVP or anti-diuretic hormone) 
and serves to send efferent signals from the SCN, which synchronizes other brain-endocrine axes and 
subsequently the rest of the organism.[112] The synchronicity of the individual cells within the SCN is an 
emergent property of the circuit as a whole. This is achieved by intraSCN synaptic and peptidergic 
signaling. The importance of the inter-cellular signaling is shown when synaptic signaling is blocked by 
tetrodotoxin (TTX) bath in tissue culture, SCN rhythmicity is dampened and signal output is 
attenuated.[32] Additionally, when SCN neurons are in a dispersed culture, each cell exhibits its own 
rhythm and phase.[167] Moreover, the period and phase of individual SCN neuronal rhythms varies widely 
between cells.[166] Within the SCN, peptidergic signaling is possibly more important than synaptic.[58] The 
SCN releases peptides in discrete temporal windows.[62] To illustrate the input of peptidergic signals, 
animal models have been created in which the genes encoding highly expressed peptides, or their 
cognate receptors, have been genetically deleted. For example, animals lacking vasoactive intestinal 
peptide (VIP, a highly expressed peptide within the SCN) or VIP’s primary receptor within the SCN, 
VPAC2, have weak or absent behavioral and neuronal activity rhythms.[19] Moreover, diffusible factors 
from transplanted fetal SCN cells, enclosed within a membrane preventing extension of synapses into 
the parenchyma, can restore behavioral and physiological rhythms in animals with ablated SCNs. The 
grafts failed to restore serum hormonal rhythms, establishing a role for synaptic signaling in some 
physiological rhythms.[84,87,142]  
1.3 Information input to the SCN 
 The SCN serves as the arbiter of external-internal homeostatic balance. To this end, the “core” 
SCN receives major environmental information from the optic nerve (retino-hypothalamic tract; RHT), 
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reciprocal signals from the intergeniculate leaflet of the thalamus (geniculo-hypothalamic tract; GHT) 
and from the median raphe nucleus within the brainstem.[135] Less substantial innervation from the 
brainstem. Each projection transmits unique information about brain and environmental state. 
The RHT transmits information about the presence and intensity of environmental light. This is 
done by intrinsic photosensitive retinoganglion cells (ipRGCs) that contain a membrane-bound light 
sensitive protein, melanopsin.[56,57,110,114,144] When light hits an ipRGC, melanopsin depolarizes the cell 
and a signal is transmitted down the RHT. The signal of light from the RHT to the SCN is transmitted by 
glutamate and PACAP, via axon terminals that innervate the retinorecipient area, or ventrolateral SCN. 
Glutamate induces neuronal excitability, seen in immediate early gene transcription, and subsequently 
induces clock gene transcription. This signaling results in a shift of the subsequent peak membrane 
firing, pulsatile release of neuropeptides, and synaptic output from the SCN. This is affected by both 
NMDA and non-NMDA receptors, initiating a variety of intercellular and intracellular signaling 
mechanisms.[29,30,41,71,155]  
Another route for photic input arises from the IGL and projects into the core of the SCN. The IGL 
receives visual image information from the environment through the optic radiation.[111,113] This 
information is initially processed and efferent information is sent to higher cortical regions while one 
projection goes back to the SCN core. These axons release neuropeptide-Y (NPY), which can shift the 
clock and modulate RHT input, and GABA, which has a variable input role when considering the extent 
of GABA-ergic neurons within the SCN.[40,100] 
The third afferent tract to the SCN comes from the median dorsal raphe nucleus. These 
projections are serotonergic, regulating arousal state, and encoding internal homeostatic and behavioral 
information. The median dorsal raphe, via serotonergic signaling, can induce phase shifts during the day 
and can modulate light-induced phase shifts during the night in the SCN.[13,14] Ablation of the 
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serotonergic input into the SCN results in larger phase advances and delays, showing the inhibitory and 
neuromodulatory effect of the median raphe.[138]  
Additional input into the SCN comes from the caudal hypothalamus, brainstem, and the pontine 
tegmentum and basal forebrain. These regions target the SCN “shell” primarily and release histamine, 
noradrenaline, and acetylcholine, respectively.[105,135] Together, these input signals to the SCN allow for 
internal physiology to synchronize to important environmental cycles. 
1.4 SCN efferent targets and signals 
 After integration of afferent information from the RHT, GHT, and median raphe nucleus, the SCN 
sends synchronization signals to the rest of the brain in the form of diffusible signals and efferent 
projections. Most of the direct synaptic targets of the SCN lie adjacent in the hypothalamus. Some of the 
best studied targets of the SCN are the subparaventricular zone (sPVZ), paraventricular nucleus (PVN), 
supraoptic nucleus (SON), ventromedial preoptic area (vmPOA), and the ventromedial and dorsal medial 
hypothalamus (vMH and dMH, respectively).[26,112,151,174]  
 Output signals from the SCN can be in the form of diffusible factors, that likely work in a 
paracrine manner. Evidence for diffusible signals were produced by ablation of an animal’s SCN followed 
by grafts fetal SCN tissue enclosed in a mesh that prevented outgrowth of neuronal projections.[84,142] 
Animals that had their SCN ablated lost behavior rhythmicity and hormonal rhythmicity. SCN grafts 
restored the behavior rhythms but failed to return hormonal rhythms. Animals that received grafts also 
exhibited the circadian period length of the graft animals instead of their own phenotype, 
demonstrating the importance of diffusible signals from the SCN.[142] 
1.5 The body’s clock is plastic 
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 The SCN receives signals from both the external and internal environment. In order to maximize 
the synchronization between the two, the SCN can shift its peak activity rhythm earlier or later, 
corresponding to an earlier sunrise or later sunset. A shift earlier is referred to as a phase advance and a 
shift to a later time is a phase delay. Whether the SCN advances or delays depends on the nature and 
timing of the signal.[41] This selective gating by the SCN allows for proper integration and interpretation 
of stimuli. Environmental light is a signal to which all rodents respond. During the day, the SCN is 
insensitive to light signals; the animal is synchronized to the ambient day-night cycle and the signal of 
light fails to elicit a phase-changing response in the SCN. However, if light signaling arrives at the SCN 
during the entrained dark/night, it signals desynchronization and phase-adjustment follows. The 
nocturnal timing of the signal determines the change in phase of the clock. If an animal is exposed to 
light during the early night, the animal’s activity rhythm is delayed. If light is given during the late night, 
then an advance occurs. Historically, light signaling has been studied through animal behavior onset. 
Rodents will run on cage wheels, which can be monitored by computer software. Thus, researchers can 
monitor when animals are awake and when they sleep, allowing for light pulses to be administered at 
specific clock times, even when the animal is in total darkness. In order to parse the signaling 
mechanisms of SCN shifts, acute or organotypic slices are used. This can be accomplished due to the fact 
that the SCN maintains many biological rhythms in constant conditions. 
Photic input is not the only route whereby an animal’s internal clock can be changed. 
Projections from the median raphe nuclei release serotonin onto the SCN and can induce phase 
advances during the subjective day and modulate phase shifts from photic input at night.[99,126,129,145] 
Input from the IGL through release of the neuropeptide NPY has the ability to modulate RHT input and 
shift the clock when applied by itself.[37,74,172] Cholinergic input from the forebrain and mesopontine 
nuclei shift rhythms at night allowing for additional non-photic feedback from internal physiological 
state.[1,41,66,89] Taken together, input independent of RHT signaling can modulate light induced phase 
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shifts or shift the SCN independently, ensuring internal physiological cycles are represented in 
rhythmogenesis over the course of the day. 
1.6 Astrocytes, GFAP, and astrocyte rhythms 
Neuroscientists of the 19th century originally classified and studied the brain and its cellular 
components based on morphological features. Sketches were made of dye filled cells and separated into 
neurons and non-neuronal cellular components.[73,123] These non-neuronal cells filled the spaces 
between neurons, offer structural rigidity for neuronal scaffolds, and provide nutritional support to the 
more electrically active components of the brain.[165] These cells were considered a new cell type, the 
neuroglia. Neuroglia were later subdivided into many different specific cell types such as astrocytes, 
oligodendrocytes, microglia, and tanycytes. Each cell type has a specific role: astrocytes encircle and 
modulate synapses and blood vessels, oligodendrocytes wrap axons increasing signaling velocity, 
microglia are the brains phagocytic immune system, and tanycytes line the large fluid filled ventricles of 
the brain. 
Although astrocytes do not exhibit membrane firing as seen in neurons, they do change 
membrane potentials in response to synaptic activity.[27] Some types of astrocytes can buffer their 
electrical activity by forming gap junctions with neighboring astrocytes creating a syncytia allowing for 
spreading over large domains. Astrocytes exhibit local and network Ca2+ fluctuations that correspond to 
astrocyte excitability. Classification of astrocytes are based on location, where fibrous astrocytes are in 
white matter while protoplasmic astrocytes are found in grey matter. Within the grey matter of the 
brain, protoplasmic astrocytes establish and maintain discrete spatial domains (or tiles) that can 
encompass as many as 100,000 synapses.[21]  These domains are not established at birth but are 
developed over time and are likely influenced by the neuronal activity within their locale.[20] Astrocytes 
also have distinct shapes which can differ within and between brain regions (Figure 1.3). 
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Evidence is building that astrocytes contribute to the emergence of intelligence and higher 
learning in organisms. Astrocytes in humans are much larger and exponentially more complex than rat 
or mouse astrocytes.[120,121] Amazingly, a study from Han et al. in 2013 successfully grafted human 
astrocyte precursor cells into neonate mouse brains.[53] Precursors grew into mature human astrocytes 
that were phenotypically similar to normal human astrocytes. These animals not only had stronger long 
term potentiation in the hippocampus of brain slices but also performed better than wild type mice in 
memory and learning tests. This study establishes astrocytes as key players in the establishment of 
learning and intelligence in mammals.    
In regards to circadian biology, astrocyte cultures from whole brain cultures have robust 
clocks.[91] Astrocytes express many genes, including the TTFL, in a circadian manner.[128] Yet astrocytes 
seem to lack a crucial quality that SCN neurons seem to have; the ability to maintain cell-to-cell 
synchronous rhythms. Cultured astrocytes, in the absence of a zeitgeber become progressively 
desynchronized.[91] Co-cultured organotypic SCN tissue can rescue the synchronicity of the cultures.[128] 
Also, if a known circadian synchronization signal, such as VIP, is given to an astrocytic culture, the cells 
become synchronized and maintain their synchrony, so long as the signal is repeated in a circadian 
manner.[91] If either the synchronizing SCN or administered synchronizing agent are removed, the 
culture again becomes desynchronized in a manner of days. The direct role that astrocytes play in SCN 
signaling and circadian rhythms hasn’t been established. Prosser et al. showed that disruption of 
astrocyte gap junctions resulted in a shift in peak SCN rhythm.[130] 
1.7 Astrocytes play many roles in the brain 
 When first discovered, astrocytes were considered merely supportive cells. They were lumped 
into a group of cells that were electrically inactive, non-neuronal and given the name glia, or “glue.” 
Scientific study for nearly 100 years was reserved for neurons since the glial cells weren’t thought to 
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contribute significantly to memory and other functional aspects of the brain. Recently, however, interest 
has spiked with the appreciation of the tripartite synapse that consists of the pre- and post-synaptic 
neurons and surrounding astrocytes that insulate, support, and signal within the synapse (Figure 1.2).  
 Astrocytes serve as the guardians of the blood-brain-barrier, enwrapping the endothelial 
vasculature with end-feet. Brain volume and fluid regulation is closely controlled by astrocytes through 
the water channel aquaporin-4 (AQP-4).[11] They also screen metabolites, osmolites, and other humoral 
factors before passage into the brain parenchyma.  
 Astrocytes play a pivotal in synapse formation during development through axonal growth by 
physical and chemotactic cues.[140,173] In a striking study, astrocyte vesicular D-serine release is integral 
for synaptic development and maturation in adult neurogenesis in the hippocampus.[150] Additionally, 
astrocytes are key in neuronal protection and cerebral responses to injury and infection. Astrocytes 
respond to neuronal injury by increasing cell volume and GFAP expression, creating glial scars that 
sequester the injured brain from healthy tissue and may facilitate proper healing of damaged axons.[35,78]  
1.8 GFAP expression, regulation, and degradation 
 Astrocytes within the CNS can be distinguished from neurons by cell shape, membrane 
conductance, and by protein markers expressed primarily by astrocytes. Cell shape and membrane 
conductance are both used to identify astrocytes in electrophysiology experiments. In situ 
immunohistochemical experiments that do not require live astrocytes utilize markers expressed only in 
astrocytes to identify these cells for study. Although astrocytes and neurons express many common 
markers, aldehyde dehydrogenase 1 (Aldh1), S100β (a calcium sequestering protein), and GFAP are 
generally considered astrocyte specific.[143,157] Although Aldh1 and S100β are considered to be pan 
astrocytic markers, these proteins give vague representations of cell location and shape. Alternatively, 
GFAP is a key structural intermediate filament expressed primarily in mature astrocytes within the CNS 
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that not only marks astrocytes but also gives a good representation of the cell’s morphology. Originally 
considered to be a static protein, research now shows that GFAP expression, polymerization state, and 
degradation is closely regulated by canonical signaling.[69] 
 GFAP expressing astrocytes can be found throughout the CNS of mammals. Structural 
differences within the CNS express higher levels of GFAP, such as the glial limitans (physical borders of 
the brain) and blood vessels. Regional GFAP differences within the brain also exist. For example, the SCN 
and intergeniculate leaflet, which both receive retinal input, express much higher levels of GFAP 
compared to the other regional nuclei.[115] Astrocytes mature from radial glial cells and begin expressing 
GFAP in response to local pituitary adenylate cyclase activating peptide (PACAP) signaling. PACAP drives 
GFAP expression through calcium dependent signaling activation of the transcription complex 
DREAM.[24] What determines the amount of GFAP expressed in quiescent mature astrocytes within the 
CNS is unknown. Inflammatory signals, hypoxia, and traumatic injury to the brain induces GFAP 
expression and astrocyte swelling through a process known as gliosis.[171] 
 As an intermediate filament, GFAP has been thought of as a static cytoskeletal filament that 
provides structural support. GFAP monomers dimerize in a parallel orientation through interactions 
within their head domains. GFAP dimers assemble antiparallel (head-tail) into filaments. Assembly and 
filament formation is regulated by phosphorylation of the head domain. Phosphorylation sites have 
been identified at four serine residues Ser-8, Ser-13, Ser-17, Ser-34 as well as threonine-7.[70] Protein 
kinase A (PKA – cAMP dependent protein kinase), protein kinase C (PKC – IP3 dependent kinase), and 
calmodulin dependent kinase 2 (CaMKII) have been shown to phosphorylate GFAP. Through 
phosphorylation cells can rapidly create a pool of dynamic monomers that aid in astrocytic process 
motility. 
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 GFAP stability and degradation in vivo are poorly understood. Gigaxonin, a protein shown to 
mediate intermediate filament degradation in both neurons and astrocytes, appears to facilitate 
ubiquitination of GFAP, targeting monomers to the proteasome.[88] It is not understood however, what 
regulates gigaxonin or how it interacts with GFAP. Paradoxically, phosphorylation is the only known 
driver of GFAP filament depolymerization and has been shown to protect GFAP from degradation.[152] 
1.9 GFAP has physiological roles in astrocytic homeostatic processes 
 GFAP is an astrocytic intermediate filament and is primarily expressed in mature astrocytes after 
postnatal day 25 (P25). It is seen in the developing brain while in utero and increases as the animal 
ages.[68] As part of the cell cytoskeleton, GFAP functions as a cellular transportation highway, trafficking 
proteins from the soma to membrane. GFAP plays a role in movement of glutamate transporters out to 
the membrane in response to network activity via an unidentified mechanism.[149] However, GFAP 
filaments do not extend all the way to the cell membrane. The filaments end some distance from the 
membrane and smaller filaments interact and extend from GFAP, primarily actin and ezrin.[80]  
 Although GFAP is a key cytoskeletal element in astrocytes, animals that have GFAP genetically 
deleted develop normally in the laboratory. The astrocytes within these animals have smaller volumes 
with fewer and less complex cell extensions.[2] Interestingly, the loss of GFAP results in stronger LTP in 
the hippocampus of brain slices, implying a role for GFAP in synaptic signaling.[98] However, the loss of 
GFAP is not always beneficial. Mice with GFAP genetically deleted have lower survival rates when there 
is direct cerebral damage or trauma.[122] Animals that were exposed to cerebral infection and immune 
inflammation had poorer outcomes.[148] Additionally, GFAP knockout animals that were challenged with 
head trauma had severe cerebral damage compared to control animals, implying a structural role for 
GFAP in overall brain stability. Astrocytes near these insults would increase GFAP expression and 
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partition the damaged brain from healthy tissue through a glial scar, preventing further damage and 
abnormal regrowth of neural circuits.  
 Previous studies indicate the total GFAP does not change with the day-night cycle but GFAP 
immunoreactivity is reduced in the SCN if the animal is kept in constant darkness or enucleated 
immediately after birth.[68,118] Animals that are placed back into a recurrent lighting schedule (LD; 12:12) 
have a concurrent increase in GFAP immunoreactivity, implying a role for light signaling in GFAP 
expression. Circadian changes in SCN astrocyte morphology and GFAP have been studied since the 
1990’s.[82] The results of these studies, however, have been contradictory and inconclusive. Differences 
between the methodology, SCN region, and the methods of analysis have resulted in a lack of 
agreement on the role of GFAP and astrocytes. Some of the earliest circadian GFAP 
immunohistochemistry-based studies were carried out by Lavaille and Serviere in the Syrian hamster 
SCN.[82] Their results reported that astrocytes exhibited differences between the light phase and dark 
phase of the hamster’s diurnal cycle. They reported that GFAP staining in astrocytes exhibited a 
significant increase and networked expression during the light phase with reduced expression at 
night.[82] These researchers have continued studying the hamster SCN and have produced several 
interesting papers showing diurnal changes in fluorescent images of GFAP immunoreactivity, with the 
highest immunoreactivity during the day and lowest at night.[82,83] Lavaille et al also showed that this 
diurnal variation of GFAP immunoreactivity continued if the animal was kept in constant darkness, albeit 
reduced in amplitude, and was lost if the animal was enucleated.[81]  
 Leone et al looked at GFAP in the mouse SCN and found similar patterns as that seen by Servier 
and Lavialle.[86] However, Moriya et al did an almost identical study and found no circadian differences in 
the GFAP expression in the mouse SCN.[116] The method used by these groups utilizes two dimensional 
brightfield microscopy at low magnifications (typically 20X objective lenses) on 3-3’-diaminobenzidine 
(DAB) stained tissue.[162]. This technique, though rapid and quantifiable, yields information about the 
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total GFAP expression in the SCN, similar to an optical Western blot, but fails to discriminate the 
expression levels within individual astrocytes. Moreover, the technique utilizes a thresholding method 
for optical density that could potentially miss finer GFAP filaments.[162]  
 Other groups have used electron microscopy to look at the finer, non-GFAP containing 
processes. Elliot and Nunez concluded from their transmission electron microscopy (TEM) study that the 
SCN astrocytes did not have diurnal differences in glial-neuronal membrane apposition.[33] However, this 
study utilized a small sample of rats and did not specify a region of the SCN studied. Likely the most 
complete series of studies to date have been completed by the French group headed by Becquet, Bosler, 
and Girardet. These studies show astrocytic diurnal changes in both GFAP and the finer, non-GFAP 
containing processes of the adult rat SCN.[16,45,97] The GFAP change was found to be in out of phase to 
the hamster rhythm seen by Servier and Lavialle, with the peak immunostaining during the night and 
lowest during the day.[8] TEM analysis of vasopressin (AVP) and vasoactive intestinal peptide (VIP) 
containing cells differed in the dynamics of fine astrocytic processes. VIP, containing cells found 
primarily in the ventrolateral retinorecipient area, showed diurnal changes while the AVP cells of the 
SCN did not.[43-45]  
 Studies that have identified seasonal and hormonal influences on GFAP expression in the SCN. 
Gerics et al observed seasonality in the rat with higher levels of GFAP at night during the winter but high 
during the day in the summer.[39] GFAP expression in the SCN can to be regulated by adrenal hormones. 
Maurel et al found no difference in GFAP staining between times ZT2 and ZT14 but if the animal was 
adrenalectomized, GFAP expression dropped.[97] Whether there is a circadian rhythm to GFAP 
expression within the SCN is confusing at best. The failure of agreement between studies, animal 
models, and methodologies leaves this topic in need of further study. 
1.10 Astrocytes and the tripartite synapse 
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 Astrocytes have emerged as important participants in synaptic regulation. The specificity 
commonly given to synaptic signaling between pre and post synaptic neurons has now been shown in 
astrocytes. Astrocytes associated with striatopallidal neuronal circuits excite only those neurons 
associated with each circuit.[93] The associations with neurons and the domains that astrocytes inhabit is 
specific to each astrocyte and persists from development of the organism through the life-course. One 
way astrocytes participate in synaptic signaling is through clearance of excitatory neurotransmitters 
within the synaptic cleft. The most prominent excitatory neurotransmitter is glutamate. Presynaptic 
neurons release glutamate into the synaptic cleft and if it remains within, can rapidly lead to 
overstimulation and death of the postsynaptic neuron (excitotoxicity). Astrocytes prevent this by 
clearing Glu, via Glu transporters GLAST and GLT-1, and recycling Glu to Gln via glutamine 
synthetase.[3,153] Glu-Gln astrocyte cycling is especially important in SCN physiology since the primary 
signal of light from the RHT is glutamate with excessive glutamate being excitotoxic. Interestingly, cell 
lines derived from the SCN are resistant to glutamatergic excitotoxicity.[17] Moreover, Glu uptake and 
Gln synthetase activity both exhibit circadian variation with higher activity of both during the light 
phase.[85] The most abundant inhibitory neurotransmitter within the brain is gamma-aminobutyric acid 
(GABA). Moreover, GABA is the most abundantly expressed neurotransmitter in the SCN, where some 
reports suggest that all neurons within the SCN are GABA-ergic.[36] Commonly considered to be an 
inhibitory neurotransmitter, GABA has mixed functions within the SCN depending on the phase of the 
clock.[48] GABA is cleared from the synapse by astrocytes through the GABA transporters GAT1 and 
GAT3. Neurons do not express GAT1 or GAT3 in the SCN, while astrocytes express these transporters 
primarily within the neuro-glial membrane appositions.[107] Thus, clearance of both glutamate and GABA 
by astrocytes is a function in all areas of the brain but is of critical importance within the SCN.  
 The second way astrocytes can regulate the excitability of neuronal networks is through the 
release of gliotransmitters. Gliotransmitters include glutamate, D-serine, adenosine triphosphate (ATP), 
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and nitric oxide (NO).[137] These factors can modulate the excitability of individual neurons, whole 
circuits, or serve as a local signal to regional astrocytes or even the astrocyte that released it. Glutamate 
can be released by astrocytes into the synaptic cleft in response to several stimuli. The context of the 
stimulus and the brain region determine the end result of the astrocytic glutamate signal. D-serine has 
been shown to play a key role in plasticity in several brain regions where it is released by astrocytes into 
the synaptic cleft. Here, D-serine allosterically binds to activate NMDA receptors, facilitating NMDA 
signaling.[117,139] ATP is released in a circadian manner by astrocyte cultures.[92] ATP serves as an 
inhibitory astrocytic signal to neurons or can act in a autocrine fashion via the purinergic receptor 
P2Y1R, causing astrocytic release of glutamate.[31] This evidence clearly shows that astrocytes not only 
maintain the synapse but actively release regulatory factors, making them essential participants in brain 
signaling. 
 A third way astrocytes regulate neuronal excitability is through astrocyte shape changes or 
morphological plasticity. One way astrocytes can change shape is through cell volume changes, which 
occur in response to increased synaptic activity.[79,156] Increased neuronal firing results in extracellular 
fluctuation of ions and neurotransmitters in the synaptic cleft. A critical ion whose concentration rapidly 
increases in the synaptic cleft during activity is K+. K+ is cleared slowly by the ATP-dependent Na+/K+ 
pump located in the membranes of both neurons and astrocytes. However, during high levels of activity, 
high K+ levels are cleared by astrocytes through the astrocytic membrane K+ channel, Kir4.1. Cell swelling 
has not been shown to be dependent on the uptake of K+ since acute slice cultures in which Na+/K+ 
ATPase and Kir4.1 were inhibited still exhibited cell swelling and extracellular space shrinkage (as 
measured by TMA+ concentration).[79]  
Astrocyte swelling/extracellular space shrinkage is effected by the astrocytic water channel, 
aquaporin-4 (AQP-4).[160] AQP-4 is enriched in astrocytes, with primary cellular localization within 
astrocytic process surrounding blood vessels and perisynaptic astrocytic processes (PAPs). AQP-4 
16 
 
enriched astrocytic end-feet help to regulate cerebral fluid flow and levels while AQP-4 in PAPs help 
regulate smaller, local changes in fluid volumes. In addition to volume swelling, astrocytes have been 
shown to change the extent of PAP intercalation between the membranes of neurons.[169] PAPs are the 
fine processes that lack larger cytoskeletal proteins and ensheath the synapse. Many key astrocytic 
proteins are localized to these fine processes, illustrating their role in astrocyte-neuron interactions. 
Originally, studies within the hypothalamus utilized immunostaining and electron microscopy to show 
retraction of PAPs in response to normal physiological stimuli such as osmotic challenge, pulsatile 
hormonal release, and reductions in blood pressure.[23,38,124] Recent improvements in imaging and 
molecular techniques have allowed for live imaging of fluorescent markers, showing the extent of PAP 
movement in response to synaptic activity.[10]    
1.11 Disease and pathology 
Circadian biology influences all aspects of life, either directly or indirectly. It comes as no 
surprise that when we are out of phase with respect to environmental cues, disease results. On the 
extreme end, rodents that are placed in a chronic jet-lag lighting schedule die much earlier than control 
animals.[28] Most of us won’t experience such extreme jet-lag, however we do send daily conflicting 
circadian signals that our brain and body must interpret through excessive night-time environmental 
lighting and social activities that disrupt sleep-wake cycles. Night shift workers have been studied 
extensively with strong correlative rates of cancer, inflammation, and metabolic syndrome.[4,75] The 
dollar value for the 15-20% of the population that suffer from daily fatigue and chronic sleepiness, loss 
of labor hours, and road and workplace accidents is estimated at over 70 billion dollars annually.[12,132] 
Unfortunately, the need to earn is greater than the detriment an individual will suffer working a night 
shift. However, the more we understand the communication between the environment, brain, and body 
the more likely we are to develop methods to treat circadian disruption. Moreover, research on the 
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diurnal plasticity of astrocytes is an important and often overlooked potential contributor to our 
understanding considering the emerging role of astrocytes in brain function and circadian rhythms. 
Currently, Alexander’s Disease is the only disease attributed to a mutation in the GFAP gene.[103] 
This mutation results in over expression of GFAP and plaques that cause pathological synaptic signaling 
and disruptions of the blood-brain-barrier. Children born with this disease die young and present 
clinically with symptoms associated with disrupted astrocyte regulation of the blood-brain-barrier, such 
as hydrocephaly. However, astrocyte pathology, whether the cause or an effect of a disease process, is 
seen in a plethora of neurological disorders: Alzheimer’s Disease, Huntington’s Disease, Amyotropic 
Lateral Sclerosis (ALS), Parkinson’s Disease, and epilepsy.[9]  
 Epilepsy is possibly the best studied neurological disease associated with astrocytic dysfunction. 
Epilepsy is one of the most prevalent neural disorders, effecting between 1-2% of the world’s 
population, costing more than 15 billion dollars annually.[34,63,159] Epilepsy is caused by a variety of 
etiologies, from traumatic brain injury, central nervous system infections, brain tumors, stroke, and 
genetic disorders.[90,127] Epilepsy is characterized by abnormally synchronized neuronal excitability across 
large spatial domains within the brain. The most common type of epilepsy is medial temporal lobe 
epilepsy (MLTE) centered in the hippocampus. 
Abnormal astrocyte shape and function is seen in epileptic brain regions, caused by focal brain 
damage, genetic abnormalities, and neuronal death. Normally astrocytes develop and maintain distinct 
spatial domains with little to no overlap with adjacent astrocytes.[20] However, in the epileptic brain, 
reactive astrocytes increase their expression of GFAP and glutamate receptors, decrease their 
expression of glutamine synthetase (GS) and Kir4.1, and increase domain overlap.[146,147] Increases in 
GFAP result in the formation of a glial scar, physically preventing neuron regrowth following damage. 
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Although believed to be a protective mechanism, glial scars have been linked to induction of epileptic 
seizures while removal of the scar is often curative.[134]  
The decrease in expression of GS and Kir4.1 both lead to increase excitability in the brain due to 
loss of GS recycling synaptic Glu to Gln. A loss of this enzyme results in prolonged high concentrations of 
glutamate in the synapse. Moreover, a lack of GS switches GABA signaling from inhibitory to excitatory, 
adding even more excitatory signaling. Kir4.1 loss results in higher extracellular potassium, which 
inhibits neuronal repolarization.[65] 
How an increase in domain overlap in epileptic regions of the brain contributes to the over 
excited phenotype of epilepsy isn’t immediately clear. However, one may hypothesize that an increase 
in domain overlap fails to allow metabolic and neurotransmitter clearance from the synaptic cleft due to 
an increase in extracellular tortuosity. In the cortex, astrocytes normally reduce their volume during the 
sleep phase, increasing the extracellular volume and decreasing tortuosity of the glymphatic system, 
allowing for daily clearance of metabolites.[170]   
1.12 Statement of problem and hypothesis 
 The study of astrocytic roles in neuronal excitability and function is a growing field. Astrocytes 
are known regulators of synaptic activity through the clearance of the synapse, release of 
gliotransmitters, and morphological changes. The role of light signaling on SCN astrocytes has yet to be 
fully understood while astrocytic contributions to circadian biology are still mainly unknown. 
Understanding the role of circadian rhythms and astrocytes in disease morbidity and mortality has the 
potential to be far reaching, with astrocytes as therapeutic interventions being possible targets. This 
study’s central hypothesis is that diurnal light and the signaling pathways it activates mediate 
astrocytic morphological plasticity in the SCN. To address this hypothesis, the following aims will be 
explored. 1) Evaluate the role of the environmental lighting schedule on glial morphology in the SCN. 2) 
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Evaluate the role of optic nerve innervation on glial morphology in the SCN. 3) Evaluate the role of Glu 
and PACAP on glial morphology in the SCN. 
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Figures 1.13 
 
Figure 1.1. The molecular transcription-translation feedback loop. Positive transcription factors CLOCK 
(CLK) and BMAL increase transcription of the Period and Cryptochrome genes as well many other genes 
known as Clock Regulated Genes. PERIOD and CRYPTOCHROME proteins are phosphorylated in the 
cytoplasm and translocate to the nucleus where they act as negative transcription factors by inhibiting 
CLOCK and BMAL binding. This positive-negative transcription-translation feedback loop takes 
approximately 24-hours, giving rise to a molecular circadian rhythm. 
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Figure 1.2. Astrocytes respond to excitatory synaptic signaling by glutamate and clear the synapse.  A) 
Neuronal activity releases excitatory neurotransmitters and neuropeptides into the synaptic cleft 
inducing activation of postsynaptic neurons as well as astrocytes. B) Receptor activation results in an 
intracellular increase of second messengers. C) Astrocyte activation results in release of gliotransmitters 
that can modulate synaptic activity. D) Astrocytes are responsible for clearing synaptic glutamate and 
potassium, and regulating water homeostasis in the synaptic cleft. This is done through channels and 
transporters for each respective factor. (Modified from Ruby et al.)[136] 
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Figure 1.3. Astrocytes are complex cells that differ between regions of the brain. A) A fluorescent 
lipophilic membrane dye outlines the complexity of an astrocyte in the dentate gyrus region of the 
hippocampus. B – D) GFAP immunoreactivity in the brains of adult rats allows for visualization of the 
astrocyte cytoskeleton in the dentate gyrus of the hippocampus (B), the suprachiasmatic nuceus (C), and 
the paraventricular nucleus (D).  Astrocyte shape and organization are visibly different between regions 
of the brain. Red scale bar equal to 50 µm. (S. Irving)  
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CHAPTER TWO 
 
DIURNAL ASTROCYTIC CYTOSKELETAL PLASTICITY WITHIN THE RAT SCN 
 
2.1 Abstract  
 Light is the primary external cue that aligns an organism’s internal physiology to the external 
environment. This cue is passed from the eye via the retinohypothalamic tract (RHT) to the 
suprachiasmatic nucleus (SCN). It is here in the body’s master clock that light information is processed 
and passed to the rest of the body. The neuronal synchronization and signaling of the SCN has 
historically been the focus of most circadian biologists. However, the role of astrocytes in SCN function 
and light signaling remains a mystery. Unfortunately, differing animal models, astrocyte parameters 
studied, SCN regions analyzed, and methodologies used have resulted in an incomplete picture of 
astrocyte morphological plasticity within the SCN. In this study, we report a significantly higher level of 
GFAP immunofluorescence in the ventrolateral region of the mid-SCN at zeitgeber time (ZT) 14 (early 
night) as compared to ZT2 (early day). Confocal analysis of individual cell GFAP cytoskeletons was not 
significantly different between early day and early night while Chi-squared analysis of branching 
distributions was significantly different. This suggests that despite individual astrocyte morphological 
heterogeneity within the SCN, GFAP branching is less complex in the early day compared to early night. 
Lastly, Western blot analysis shows a significant difference between filamentous and soluble GFAP, with 
early day having higher levels of soluble GFAP compared to early night. Taken together, these results 
demonstrate a diurnal rhythm in the astrocyte cytoskeleton, which has the potential to play a role in 
SCN physiology. 
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2.2 Introduction 
Diurnal light is the primary signal animals use to anticipate and synchronize internal and 
external environments.  Synchronization requires transmission and centralized integration of the signal, 
as well as output to the rest of the brain and body. Transmission of photic input travels from the eye to 
the brain via the retinohypothalamic tract (RHT).[105] Integration, interpretation, and output of this 
information is done within the body’s master clock, the suprachiasmatic nucleus (SCN). The SCN is a 
bilateral pair of nuclei consisting of about 20,000 neurons immediately dorsal to the optic chiasm.[50] The 
neurons of the SCN coordinate with each other through synaptic and peptidergic signaling, creating an 
emergent, cohesive circadian rhythm.[106] The SCN circuit then transmits biological time to the rest of the 
brain and body by way of synaptic and humoral signals. 
The extent to which astrocytes influence this organization and signaling mechanism of circadian 
rhythms has yet to be elucidated.[130] A recent study by Brancaccio et al. identified astrocytic calcium and 
glutamate tone in the SCN during the subjective night as being key regulators of inhibitory GABAergic 
signaling. Interestingly, only astrocytes within the dorsomedial region of the SCN seemed to exhibit this 
circadian behavior.[18] Astrocytes can influence synaptic activity through clearance of neurotransmitters 
and ions, release of gliotransmitters, and movement of perisynaptic astrocytic processes.[10,137] Although 
synaptic clearance and release of gliotransmitters is well studied, the extent to which astrocytic 
movement can modulate synaptic activity is poorly understood. This lack of knowledge is due in part to 
the difficulty of visualizing astrocyte morphological dynamics. Several techniques have historically been 
utilized including electron microscopy, dye filling of whole astrocytes, and staining of the cell 
cytoskeleton.[8,21,33] High resolution analysis using an electron microscopy give nanometer resolution of a 
small sample of the astrocytic membrane and requires special sample treatment, in addition to requiring 
an electron microscope, which many be difficult to access. More recent studies have utilized injection of 
small fluorescent dyes to visualize the cell’s volume. Although this gives more information of the 
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astrocyte shape it requires live dye-filling of single astrocytes in acute slice culture. A more generalized 
approach to analyzing astrocyte morphology is through immunohistochemical staining of an astrocyte 
specific cytoskeletal protein, glial fibrillary acidic protein (GFAP). This approach can yield information 
about a much larger sample of astrocytes, including whole brain regions. GFAP staining is limited by the 
fact that GFAP only reveals 13% of the cell volume and does not extend to the cell membrane.[21] 
However, this technique has been the most utilized approach when analyzing glial morphology in the 
SCN. 
Our current understanding of GFAP’s physiological role in the central nervous system (CNS) is 
limited. Only when inflammation, neurotoxicity, or acute physical damage to the brain occurs do we see 
changes in GFAP expression and swelling of astrocyte cell bodies creating a physical barrier between 
healthy and damaged or necrotic tissue, indicative of a scarring event. Dynamic expression or changes in 
GFAP morphology in normal physiological states is poorly understood at best.  
Unfortunately, research is murky in regards to the role environmental signals play in regulation 
of SCN astrocytic GFAP dynamics. Previous studies have failed to agree on circadian changes in GFAP 
immunofluorescence or somal apposition between neurons and astrocytes in the SCN around the clock. 
This is confounded by the variation in animal models, techniques used, and anatomical region studied. 
For example, Servier and Lavialle’s studies within the Syrian hamster reported the first diurnal pattern in 
GFAP immunofluorescence.[81-83,141] Contrasting this, studies in the rat SCN have shown either no change 
in GFAP immunostaining or appear to be phased differently to what Servier and Lavialle observed in the 
hamster.[8,116] Elliot and Nunez used transmission electron microscopy (TEM) to look at the extent of 
somal apposition of neurons and astrocytes in the rat SCN every 4 h and found no difference across the 
day. Becquet et al. found significant changes with respect to time of day and region studied.[8,15,33,43,45] 
Interestingly, the ventrolateral area of the SCN, specifically the VIPergic region, appears to be the only 
area exhibiting astrocyte plasticity in membrane apposition with neurons.[43,44] Synaptic coverage at the 
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EM level is highest during the night and lowest during the day.[16] This may relate to the research by Xie 
et al. that observed an increase in the tortuosity of the extracellular space in the cortex of the conscious 
mouse and decreased while asleep.[170] This diurnal change in tortuosity allows for clearance of 
metabolites during sleep and seems to be dependent on retraction of astrocyte membranes. Whether 
this type of morphological plasticity plays a role in the SCN’s sensitivity to RHT signaling during day 
versus night remains to be elucidated. 
Here we show that GFAP immunostaining does exhibit a diurnal difference with higher 
immunostaining in the early night compared to early day. We also show that although there are not 
significant differences in the branching complexity of the total population of individual astrocytes in the 
SCN between early day and early night, there is a significant shift in the population distribution of cell 
branching where early day has fewer cells with more complex GFAP branching compared to early night. 
Lastly, we show that the total amount of GFAP does not change between early day and early night but 
the polymerization state of GFAP is dynamic. We found that early day SCN tissue has significantly more 
soluble GFAP compared to early night. We hypothesize that this shift from the insoluble or filamentous 
form to a soluble or monomeric form is likely due to a post-translational modification of GFAP that 
prevents filament polymerization.  
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2.3 Materials and methods 
Animals 
 All animal experiments were conducted in full compliance with federal guidelines for humane 
animal research and according to an IACUC approved protocol. Adult Long Evans (LE/Blue Gill) rats were 
kept on a 12-h:12-h light/dark lighting schedule. Animals were sacrificed at two zeitgeber times (ZTs). 
ZT2 refers to two hours after lights were turned on and ZT14 refers to two hours after lights were turned 
off. Seven adult male rats were sacrificed and analyzed at ZT2 and eight adult male rats were sacrificed 
at ZT14. These times were chosen as maximum and minimum of GFAP immunoreactivity and complexity 
based on previous work in the Gillette Laboratory by Dr. Harry Rosenberg and other published 
studies.[8,81,82] 
Tissue preparation and fixation 
 ZT2 animals were sacrificed with lights on while animals at ZT14 were sacrificed in a dark room 
with a hood to avoid light from hitting the retina. Animals from both groups were anesthetized by an 
intraperitoneal dose of pentobarbital (1 mL per animal) within 20 min of the designated time points. 
Following anesthetization, animals were transcardially perfused with 300 mL of cold normal saline (0.9% 
sodium chloride) followed by 300 mL of cold fixative containing 4% paraformaldehyde. After fixation, 
animals were decapitated and the brains removed carefully to avoid damage to the ventral brain and 
optic nerves. Brains were then post-fixed for 24-h. After post fixation, brains were then placed into PBS 
and sectioned using a vibratome to a thickness of 40 µm.  
Animals used for Western blots in GFAP solubility analyses were sacrificed without anesthetic. 
Animals were briefly disoriented by spinning and rapidly decapitated with a guillotine. Brains were then 
removed and 500 µm thick hypothalamic slices containing SCN (as observed from the characteristic 
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shape of the optic chiasm) were sectioned. The SCN was then punched out using a 1mm biopsy punch 
and rapidly frozen on dry ice.  
Immunohistochemistry 
 Brains were stained for GFAP in groups of four, with two brains from each experimental group 
stained together. This was repeated four times for a total of seven brains at ZT2 and eight brains at 
ZT14. Following slicing, tissue was placed in a blocking/permeablization (Triton-X with 5% goat serum) 
solution for 1 h. Tissue was then washed three times in PBS. Slices were then incubated for 48 h at 4˚C in 
primary antibody. For GFAP immunohistochemistry, the primary antibody used was mouse anti-GFAP 
(1:10,000 dilution; EMD Millipore, Bellirica, MA). Following primary antibody, tissue was washed three 
times in PBS. Tissue was incubated with secondary antibody conjugated to a fluorophore for 2 h at room 
temperature. The excitation wavelength for the fluorophore conjugated to the secondary GFAP 
associated antibody was 568 nm. Following secondary antibody, tissue was washed three times and 
mounted on gel-coated coverslips and allowed to dry. Once tissue is dry, ProLong Gold Antifade 
(ThermoFishcer Scientific, Life Technologies, Grand Island, NY) was applied and the slide is coverslipped. 
Slides were allowed to cure for 24 h at room temperature in the dark. After curing, clear nail polish was 
applied to the coverslip-slide edges to seal the ProLong and allowed to dry. Tissue was then taken to the 
microscopy facility and imaged. 
Image acquisition 
 Rigorous testing of fluorescence intensities at both time points showed that small changes of 
laser power, gain intensity, or amplifier offset created differences in observed branching complexity by 
up to 50 percent (data not shown). Because of this, the researcher was blinded to the time point being 
analyzed, and images were obtained in a reproducible and constant manner. Fluorescent images were 
obtained using a Nikon Optiphot-2 microscope (Nikon, Japan) with a 4X air (0.13 DL/1 NA) lens with a 
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Texas Red dichroic mirror. Images were captured using a SPOT RT3 (Model 25.4 2 Mp Slider, Diagnostic 
Imaging, Sterling Heights, MI) camera and software. Three dimensional mages were acquired on a 
LSM510 Meta scanning confocal microscope (Zeiss Microscopy, Germany). To image GFAP, a 568 nm 
laser (30% laser power, 850 master gain, -0.10 digital offset) and a 40x oil lens (1.4 NA) were used. One 
brain slice containing the middle SCN was chosen from each brain. Two images, one from each bilateral 
SCN, were then taken of the vetrolateral region of the SCN immediately dorsal to the optic nerve. Three 
dimensional Z-stacks are taken with a depth resolution of 0.5 µm. Upper and lower vertical limits of 
tissue imaging is set accordingly to the presence of signal during scanning mode and varied from slice to 
slice. 
Gel electrophoresis and Western blotting 
 Methods used for gel electrophoresis and Western blotting were modified from Hsiao et al.[64] 
Flash frozen tissue was lysed with a pestle on ice using 100 µl lysis buffer for 15 min. Lysis buffer 
consisted of 0.5% Triton-X100 v/v, 2mM Tris-HCl, 2mM EDTA, 2mM phenylmethylsulfonyl fluoride, 
EDTA-free protease inhibitor cocktail (Roche), protein phosphatase inhibitor cocktails set I and set II 
(Millipore), at pH 7.0. Following lysis, 30 µl was removed and kept as a total sample. Cells were then 
spun at 14,000 x g at 4˚C for 10 min. Protein concentrations were calculated using a Pierce BCA protein 
assay kit (Thermo Scientific). Soluble fraction samples were very dilute, therefore only 10 µg protein 
from total and supernatant were placed in running buffer (1% SDS w/v, 50mM Tris-HCl, 5% glycerol, 
0.05% bromophenol blue w/v, 0.25% betamercaptoethanol v/v, at pH 6.8) and boiled for 5 min. 
Samples were separated on a 10% polyacrylamide gel and wet transferred to polyvinyldifluoride 
(PVDF) membranes and blocked with 5% milk in tris-buffered saline with 5% triton (TBST) for 1 h at 37˚C. 
Blots were then probed with the same GFAP antibody as used in IHC at a dilution of 1:10,000 overnight 
in 1% milk in TBST. As a loading control, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was 
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probed with anti-GAPDH antibody at 1:10,000 dilution overnight. Blots were washed 3 times for 5 min 
with TBST following primary antibody incubation. Horse radish peroxidase conjugated secondary (goat 
anti-mouse antibody) was used at a dilution 1:1,000 in 1% milk in TBST for 1 h at room temperature. 
Following secondary antibody, blots were washed 3 times for 5 min with TBST. Blots were then 
incubated with SuperSignal Chemiluminescent Substrate for two minutes and imaged using a digital 
camera. Exposure was set to avoid saturation of signal for any given band. Relative intensities were 
calculated by dividing the observed intensity of GFAP by the observed intensity of the tubulin signal. 
Analysis and statistics 
 For 4x immunofluorescence studies researchers were blinded to the identification of slices when 
analysis was being done. Fluorescent images were imported into ImageJ software (ImageJ, NIH). ROIs 
were drawn around both SCN nuclei. As a staining control, the subparaventricular zone (SPZ), which did 
not change with respect to time of day, was used as a control region. Average pixel intensity from each 
SCN was divided by the average pixel intensity from the SPZ from the same brain. The resulting value 
was then considered a normalized value, which allowed the researchers to control for potential 
immunostaining variance between brains. Fluorescent values were analyzed using a two-tailed Student’s 
t-test with a 95 % confidence interval.  
For confocal images, three dimensional 8-bit Z-stacks were loaded into Imaris software 
(Bitplane, Concord, MA). The “Filaments” function was used to automap the GFAP cytoskeleton. The 
maximum width of GFAP filaments was set as 5 µm while the minimum was set at 0.5 µm, which 
approaches the optical resolution for the system used. Voxel threshold was set at 60 out of a total of 
256 grey scale values. Due to the intercalation and varying signal intensities within the SCN, cells were 
manually chosen based on the center of intensity and observed branching. Total length, area, and 
volume were calculated while GFAP branch end points were used as a metric of individual cell 
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complexity. Branch points were defined as the point at which the fluorescent signal fell below the set 
voxel threshold at the end of a defined branch. Branch terminal points were logarithmically transformed 
creating a standard distribution required for parametric statistical analysis. Statistical tests were done 
using the mixed model ANOVA in Statistical Analysis Software (SAS, JMP). Statistical significance was set 
at 95 % confidence interval. For Chi-squared analysis, individual cell branch end points were binned by 
100 branches up to 400 branch end points. Chi-squared analysis was conducted within Prism 6 
(GraphPad). 
2.4 Results 
Fluorescence analysis of GFAP immunoreactivity. 
To determine whether the polymerization state of GFAP exhibits diurnal variation, GFAP 
immunostaining was performed. This analysis allows for the measurement of filamentous levels of GFAP 
at early day and early night. The region of interest (ROI) for each SCN was centered on the ventrolateral 
SCN from each brain, which was also had the highest intensity observed for GFAP immunostaining. 
Areas within the SPZ were used as control regions to standardize immunofluorescence for each SCN 
analyzed due to potential immunostaining differences between slices (Figure 2.1B-C). Our results show 
significant differences in GFAP filament immunostaining within the SCN, with higher intensities at ZT14 
compared to ZT2 (Fig. 2.1A). These results are consistent with previous studies that examined 
immunostaining intensity and electron microscopy of the adult rat SCN during the day and night.[8,51]  
GFAP branching reconstruction and analysis 
 Although GFAP fills only a portion of the astrocytic extension, branching of GFAP extends into 
astrocytic processes and indirectly supports the cell membrane. Because of this, GFAP filament branch 
end points were used as a measure of astrocyte morphological complexity. In our study, large variation 
between individual GFAP branch end points was observed. The branch end-point results did not exhibit 
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a normal distribution and therefor were logarithmically transformed to obtain a normal distribution for 
statistical analysis. Our results were not significant in any of the metrics analyzed from Imaris software, 
including GFAP length, area, volume, or branch terminal points within the SCN (Fig 2.3B). However, Chi-
squared analysis of the distribution of branch end points binned into groups every 100 branch end 
points at ZT2 and ZT14 was significantly different (p < 0.05), with ZT14 having a greater number of cells 
with more branch terminal points than compared to ZT2 (Fig 2.3). 
Diurnal changes in filamentous and soluble GFAP levels 
 To confirm our observed changes in GFAP immunofluorescence, we conducted a Western Blot 
based study probing the differences in solubility of GFAP in the SCN tissue punch at ZT2 and ZT14. We 
first confirmed that the total amount of GFAP and GAPDH were not changing between early day and 
early night (Figure 2.4A&B). We then separated the filamentous from soluble GFAP using high speed 
centrifugation (14,000 rcf). We observed significantly higher levels of soluble GFAP in the early day 
compared to early night (Figure 2.6). These results agree with the hypothesis where GFAP 
immunostaining represents the polymerized state. As GFAP becomes soluble, the immunostaining 
decreases within the astrocytes in the brain slice. 
2.5 Discussion 
 GFAP is a key structural protein in mature astrocytes of the CNS.[98,149] Moreover, GFAP is 
integral in normal astrocytic function in the tripartite synapse where they are responsible for clearance 
of glutamate, a potentially exitotoxic neurotransmitter.[2] This role is likely crucial in the SCN, which 
receives significant glutamatergic input from the RHT when light is present in the environment. Whether 
diurnal changes in RHT signaling can drive changes in the GFAP cytoskeleton in adult rat SCN is 
unknown. Our study has identified a significant difference in the intensity of immunofluorescence in the 
ventrolateral SCN, with higher intensity at ZT14 compared to ZT2, which agrees with previous studies 
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immunofluorescence and electron microscopy or the rat.[8,43,51] Moreover, utilizing a 3D immunostaining 
reconstruction method, we have identified a shift in branching of the astrocytic cytoskeleton within the 
SCN. Lastly, we have identified a previously unknown shift in soluble GFAP levels in SCN tissue. These 
observed dynamics could be due to changes in GFAP phosphorylation state, which causes 
depolymerization and solubilization, resulting in decreased immunostaining, fewer branches in the GFAP 
cytoskeleton, and a shift from filamentous to soluble GFAP.[69,70] 
Here we confirm using GFAP immunostaining that GFAP is dynamic in the adult male rat SCN. 
We showed that GFAP staining is significantly higher in the early night compared to the early day. We 
then sought to confirm the results observed by Dr. Harry Rosenberg, which stated that GFAP branching 
complexity was higher in the early day compared to the early night. Here we found that GFAP branching 
reconstructions were not significantly different between ZT2 and ZT14. The lack of significance may be 
due to the fact that branch terminal point values were absolute and not compared to any internal 
control creating a large amount of variation. Branch terminal points had to be logarithmically 
transformed, creating a normal distribution, which was required for statistical analysis. This large 
variation of branch terminal points between individual astrocytes within the same brain suggests the 
astrocytes are not a heterogeneous population with respect to branch complexity. This observation 
together with the variation between animals makes statistical analysis a nightmare. Without a control or 
standard to normalize branch terminal points between samples fails to address the potential variation 
between perfusion, staining, and anatomical differences of each rat, which influences the data collected. 
This fails to agree with previous results seen by Dr. Harry Rosenberg in the Gillette Laboratory. 
His results showed that GFAP branching was significantly higher at ZT2 and lowest at ZT14. The 
contradicting results between these two studies may be explained by the imaging technique, staining 
methods, and sex differences in animals utilized by each researcher. The current study was done with a 
rigorous setting for the image acquisition, which was reproduced for each image obtained. In fact, a 
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change of amplifier gain by as small as 5 % on image acquisition can result in a 50 % reduction of 
observable branch terminal points (data not shown). The current study also had the primary researcher 
blinded to the time point groups until the end of analysis. Taken with the fact that the GFAP 
cytoskeleton only represents roughly 13 % of the cell volume, the researcher does not feel that this 
experimental design is a reliable and reproducible way to measure astrocyte GFAP cytoskeletal 
complexity.[21] 
 Finally, we show that the solubility of GFAP at ZT 2 is significantly higher than at Z 14 . This 
observation agrees with the previous immunostaining results in the rat SCN.[43,51] We hypothesize that at 
ZT 2 GFAP staining is less in immunofluorescence images likely due to the shift from filamentous into a 
soluble state. Observable diurnal changes in GFAP is exciting, especially since the change from 
filamentous to soluble GFAP is driven by phosphorylation of the head domain.[69,70] Moreover, 
phosphorylation of GFAP protects it from degradation.[152] Whether or not this change is a circadian 
clock-driven phenomenon or is instead driven by an unknown signal to astrocytes in the SCN is currently 
unknown. However, cytoskeletal changes that underlie the observed differences in immunostaining 
intensity are still unknown. This diurnal variation is likely due to a change in complexity of the GFAP 
cytoskeleton although the significance at the time points studied is over shadowed by the heterogeneity 
of individual astrocyte cytoskeletons. Our Western blot results showing a shift from filamentous to 
soluble GFAP explains our observed diurnal GFAP immunostaining intensity results and the observed 
shift in reconstructed branching complexities in the population distributions between early day and 
early night. Taken together, an increase in filamentous GFAP would lead to an increase in signal intensity 
measured by immunofluorescence imaging while depolymerization would result in lower imaging 
intensities. 
The role that diurnal astrocytic plasticity of GFAP could be playing in SCN physiology and rhythm 
generation is still unknown. One hypothesis lies in clearance of glutamate from the RHT-SCN synapse 
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during the light phase. Not only are these levels of glutamate excitotoxic in most regions of the CNS, but 
the neuronal rhythms of the SCN fail to respond to glutamatergic signaling during the day despite 
increasing firing frequency.[102] Moreover, an SCN-derived cell line is resistant to glutamate 
excitoxicity.[17] Additionally, astrocytic shape change is established in regulation of extracellular space 
and clearance of the glymphatic system of the cortex. Oberheim et al. observed that adrenergic 
signaling regulated an increase in extracellular space clearance while mice were asleep (during the 
subjective day), suggesting that astrocytic volumes were changing to allow metabolic clearance.[170] The 
connection between GFAP dynamics, astrocyte morphological plasticity, and their role in the tripartite 
synapse within the SCN are still unknown. 
The signals driving the observed change in the astrocyte cytoskeleton are still unknown. One 
hypothesis is that PACAP and glutamate, which have been shown to activate signaling mechanisms 
upstream of GFAP phosphorylation and subsequent depolymerization, may be released during the day 
and act directly on SCN astrocytes.[69,70,95,96,158,163] Glutamate is the retinal signal for the presence of light 
while PACAP has been shown to colocalize in RHT-SCN synapses with glutamate.[30,54,101] Our future 
experiments explore RHT signaling in the SCN in order to identify potential mechanisms behind the 
observed diurnal dynamics of GFAP.  
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2.6 Figures 
 
Figure 2.1. Fluorescent intensity of GFAP immunoreactivity is significantly different between ZT2 and 
ZT14. A.) Fluorescent intensity was measured at ZT2 (n=7) and ZT14 (n=8) and analyzed with an unpaired 
two tailed Student’s t-test. * p < 0.05. B.) Representative fluorescent images from ZT2 and ZT14. ROIs in 
red are 230 µm2. SPZ ROIs were the same size as SCN ROI. (S. Irving) 
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Figure 2.2. GFAP complexity does not change significantly between early day and early night. A-C.) GFAP 
length, area, and volume do not change significantly between early day and early night. Student’s t-test 
for each measurement. P >0.05. n = 5 animals per time point. 
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Figure 2.3. Astrocytic population distributions of GFAP complexity changes between early day and early 
night but individual cell complexity of the population does not. A.) The distribution of astrocytes with 
larger or smaller branch terminal points changes significantly between ZT2 and ZT14. The population 
distribution of numbers of cells with different total numbers of branch points are significantly different 
between ZT 2 and ZT 14. Chi-squared contingency test. * =  P < 0.01. N=5 animals, 95 cells per time 
point. B.) Average branch terminal point analysis between ZT 2 and ZT 14 was not significant for the 
total population of cells. Unpaired Student’s t-test. P > 0.05, n = 5 animals per time point. Between 16-
20 cells per animal. C.) Example images of SCN GFAP branching at ZT2 and ZT14. Scale bar = 50 µm.  
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Figure 2.4. Solubility of GFAP in the 500 µm SCN punch is higher at ZT2 compared to ZT14. A.) Total 
GAPDH was used as a loading control and was confirmed to be not significantly different between ZT2 
and ZT14. Student’s t-test p > 0.05. n = 6 animals per time point. B.) Total GFAP was not significantly 
different between ZT2 and ZT14. Student’s t-test p > 0.05. n = 6 animals per time point. C.) 
Representative Western blot with total samples and supernatant samples from ZT2 and ZT14. D.) 
Soluble to total GFAP ratios were significantly decreased by 67% at ZT14 compared to ZT2. p < 0.05. n = 
6 animals per time point.  
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CHAPTER THREE 
INVESTIGATING THE ROLE OF THE OPTIC NERVE ON SCN ASTROCYTIC CYTOSKELETAL PLASTICITY 
3.1 Abstract 
 Circadian rhythms synchronize an organism’s internal clock to external timing cues. Perhaps the 
strongest, most robust timing cue an animal receives from the environment is light. In mammals, this 
cue is transmitted from the eye to the brain via the optic nerve. Within the retina there reside 
photosensitive cells that contain melanopsin, which is sensitive to light. The axonal projections these 
intrinsic photosensitive retinoganglion cells (ipRGCs) send to the suprachiasmatic nucleus (SCN) are 
known as the retinohypothalamic tract (RHT).[110] These ipRGCs synapse on a region of the SCN known as 
the retinorecipient area.[56,57] TEM studies in this region have shown changes in the astrocytes 
surrounding neurons expressing vasoactive intestinal peptide (VIP) while astrocytes surrounding 
vasopressinergic (AVP) neurons failed to change around the clock.[8] Moreover, proper RHT innervation 
is in part responsible for the correct development of SCN components, including both neurons and 
astrocytes.[81,118] Our study focused on the role of the retina in adult rats on expression and complexity 
of the astrocytic intermediate filament GFAP in the SCN. Here we identify retinal signaling as the primary 
driver of SCN astrocyte GFAP dynamics. 
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3.2 Introduction 
The primary input for photic information to the brain is via the retinohypothalamic tract (RHT). 
The RHT synapses on the SCN, the brain’s master clock. The SCN interprets this timing information and 
synchronizes the rest of the brain and body. In fact, the two regions of the brain that receive light 
information from the retina, the SCN and intergeniculate leaflet (IGL), show increased levels of GFAP 
staining relative to other regional brain tissue.[115] In addition to relaying light information, the RHT is 
responsible for proper post-natal development of astrocytic and neuronal elements within the 
SCN.[68,108] Maturation of cellular elements within the SCN is dependent upon photic stimulation of the 
retina. Animals who have their eyes removed after birth have significantly reduced numbers of GFAP 
containing cells along with a reduction in the amount of total GFAP expressed in SCN.[68,116] Animals that 
have an intact optic nerve but are kept in constant darkness for 50 days also have reduced GFAP staining 
intensity, but GFAP levels return when the animals are placed in a 12-h light/dark cycle.[68] The extent to 
which the retina regulates astrocyte activity in the adult rat SCN is unknown. We have previously 
identified a shift in GFAP polymerization between early day and early night in the adult rat SCN under a 
12-h light/dark cycle. However, the extent to which the retina regulates these dynamics has yet to be 
studied. Glutamine synthetase, the astrocytic enzyme responsible for recycling glutamate into glutamine 
in the glutamate-glutamine cycle, normally has peak activity while lights are on but in enucleated 
animals this peak is shifted to the rat subjective night, suggesting a role for the optic nerve in normal 
SCN astrocyte function.[85] These studies suggest a role for the optic nerve in SCN development and 
show a previously understated level of astrocytic plasticity within the SCN that may be regulated by 
retinal signals. 
The RHT releases glutamate within the SCN when an animal’s eyes are exposed to light. Both 
neurons and astrocytes within the SCN express receptors for light signals. Although the neuronal 
response to glutamate in the SCN has been thoroughly studied, astrocytic responses are largely 
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overlooked. Therefore we may look to astrocytic responses to glutamatergic signaling in other regions of 
the brain as a starting point for SCN astrocyte experimental design. Glutamate signaling can induce 
phosphorylation of GFAP in post-natal hippocampal and cerebellar brain slices but fails to induce 
phosphorylation in older animals.[76,77] However, excitatory signaling within the hippocampus in adult 
brain slices induces movement of fine perisynaptic astrocytic processes (PAPs) around the synapse. This 
movement is associated with greater synaptic stability and long term potentiation (LTP).[10] It should be 
noted that the GFAP cytoskeleton does not reach the cell membrane is not thought to enter the PAP. 
 Although identified as a regulator of GFAP in the developing SCN, the extent retinal signaling 
plays in the already developed SCN is largely unknown. The level of plasticity adult astrocytes can 
express in the SCN is a novel and exciting field of research. In our study we show that environmental 
light is the primary driver of GFAP polymerization state within the SCN. Additionally, we show that an 
intact retina is required for basal levels of GFAP solubility and long term enucleation reduces the overall 
GFAP expression within the SCN relative to a control hypothalamic region. These results suggest a retinal 
signal (or signals) regulates the solubility state of GFAP within the SCN in a diurnal manner and that the 
polymerization dynamics we have previously described are primarily regulated at the level of the retina 
and not by an astrocytic molecular clock or by SCN neuronal signaling. 
3.3 Materials and methods 
Animals 
 All animal experiments were conducted according to IACUC approved protocol. Long Evans 
(LE/Blue Gill) age matched groups were separated into four groups; L:D, D:D, enuc-short, and enuc-long. 
The L:D group was not enucleated and kept on a 12 h:12 h L:D cycle. This group consisted of 16 animals, 
8 for each time point (ZT 2 and ZT 14). The D:D group was also not enucleated and was kept in constant 
darkness starting at ZT 0 for an additional 48 h. After 48 h, the animals were sacrificed at the 
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corresponding circadian times (CT), CT 2 and CT 14. Therefore, CT 2 animals were kept in constant 
darkness for 50 total hours and CT 14 animals for 62 h. The amount of time kept in constant darkness 
should abolish any light signaling the retina received while keeping the animal on the anticipated 
circadian time. Two enucleated animal groups were made, enuc-short and enuc-long. Each group 
consisted of 8 animals. Enuc-short animals were enucleated at ZT0. These animals were allowed to 
recover for at least 48 h followed by sacrifice at subjective CT 2 and CT 14. Therefore, these animals 
were sacrificed approximately 50 and 62-h post-enucleation. Enuc-long animals were enucleated while 
lights were on and allowed to recover for at least 3 months and sacrificed at ZT 2 and ZT 14. 
Enucleation procedures 
Enucleated group animals were anesthetized with inhaled 10% isoflurane mix and enucleated. 
Eye sockets were packed with antibiotic swabs and sutured shut. Enucleated animals were allowed to 
recover for at least 2 months. Age matched control animals were kept in the same room during 
enucleation and housed in the same room as the experimental group until sacrificed. Control and 
experimental rats kept in a 12 h:12 h L:D lighting schedule were sacrificed at two zeitgeber times, ZT 2 
and ZT 14. ZT 2 refers to two hours after lights were turned on and ZT14 refers to two hours after lights 
were turned off. Enucleated animals were sacrificed at the same time as controls despite being on CT 
due to the lack of environmental light input to the circadian system. Circadian timing for long enucleated 
animals was subsequently assessed by PERIOD2 staining. Age-matched animals from control and 
enucleated groups were sacrificed on the same day. 
SCN tissue punch preparation 
Animals used for Western blots in GFAP solubility analyses were sacrificed without anesthetic. 
Animals at ZT2 and all enucleated groups were rapidly sacrificed and decapitated with lights on. Animals 
at ZT14 and all DD groups were sacrificed with the lights off. Animals were briefly disoriented by 
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spinning and rapidly decapitated with a guillotine. Brains were then removed and 500 µm thick 
hypothalamic slices containing SCN (as observed from optic chiasm) were sectioned. The SCN was then 
punched out using a 1mm biopsy punch and rapidly frozen on dry ice. 
Gel electrophoresis and Western blotting 
 Methods used for gel electrophoresis and Western blotting were modified from Hsiao et al.[64] 
Flash frozen tissue was lysed with a pestle on ice using 100 µl lysis buffer for 15 min. Lysis buffer 
consisted of 0.5% Triton-X100 v/v, 2mM Tris-HCl, 2mM EDTA, 2mM phenylmethylsulfonyl fluoride, 
EDTA-free protease inhibitor cocktail (Roche), protein phosphatase inhibitor cocktails set I and set II 
(Millipore), at pH 7.0. Following lysis, 30 µl was removed and kept as a total sample. Cells were then 
spun at 14,000 x g at 4˚C for 10 min. Protein concentrations were calculated using a Pierce BCA protein 
assay kit (Thermo Scientific). Soluble fraction samples were very dilute, therefore only 10 µg protein 
from total and supernatant were placed in running buffer (1% SDS w/v, 50mM Tris-HCl, 5% glycerol, 
0.05% bromophenol blue w/v, 0.25% betamercaptoethanol v/v, at pH 6.8) and boiled for 5 minutes. 
Samples were separated on a 10% polyacrylamide gel and wet transferred to polyvinyldifluoride 
(PVDF) membranes and blocked with 5% milk in tris-buffered saline with 5% triton (TBST) for 1 h at 37˚C. 
Blots were then probed with the same GFAP antibody as used in IHC at a dilution of 1:10,000 overnight 
in 1% milk in TBST. As a loading control, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was 
probed with anti-GAPDH antibody at 1:10,000 dilution overnight. Blots were washed 3 times for 5 
minutes with TBST following primary antibody incubation. Horse radish peroxidase conjugated 
secondary (goat anti-mouse antibody) was used at a dilution 1:1,000 in 1% milk in TBST for 1 h at room 
temperature. Following secondary antibody, blots were washed 3 times for 5 minutes with TBST. Blots 
were then incubated with SuperSignal Chemiluminescent Substrate for two minutes and imaged using a 
digital camera. Exposure was set to avoid saturation of signal for any given band. Relative intensities 
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were calculated by dividing the observed intensity of GFAP by the observed intensity of the tubulin 
signal. 
Fixed tissue preparation 
 Brains from all experimental group animals were removed at ZT/CT 2 and ZT/CT 14 for each 
group, respectively. ZT2 and all enucleated animals were sacrificed with the lights on. ZT 14, CT 2 D:D, 
and CT 14 D:D animals were sacrificed in a dark room with a hood covering the head to avoid any 
potential environmental light hitting the retina. Animals from all groups were anesthetized by an 
intraperitoneal dose of pentobarbital (1 mL per animal) within 20 min of the designated time points. 
Following anesthetization, animals were transcardially perfused with 300 mL of cold normal saline (0.9% 
sodium chloride) followed by 300 mL of cold fixative containing 4% paraformaldehyde. After fixation, 
animals were decapitated and the brains removed carefully to avoid damage to the ventral brain and 
optic nerves. Brains were then post-fixed for 24 h. After post fixation, brains were then placed into PBS 
and sectioned using a vibratome to a thickness of 40 µm. Brains were serially sliced on a vibratome into 
40 µm thick slices. Alternating slices were used for GFAP and PERIOD2-DAB staining. 
Immunohistochemistry - GFAP 
Following slicing, tissue was placed in a blocking/permeablization (Triton-X and 5% secondary 
host serum) solution for 1 h. Tissue was then washed three times in PBS. Slices were then incubated for 
48 h at 4˚C in primary antibody. For GFAP immunohistochemistry, the primary antibody used was mouse 
anti-GFAP (1:10,000 dilution; Millipore). Following primary antibody, tissue was washed three times in 
PBS. Tissue was then incubated with a goat anti-mouse secondary antibody conjugated to a 568 nm 
fluorophore (Molecular Probes) for 2 h at room temperature. Following secondary antibody, tissue was 
washed three times and mounted on gel-coated coverslips. Tissue was allowed to dry. Once tissue was 
dry, ProLong Gold was applied and tissue is cover slipped. Slides were allowed to cure for 24 h at room 
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temperature. After curing, clear nail polish was applied to the coverslip-slide edges to seal the ProLong 
and allowed to dry. Tissue was then taken to the imaging facility to be imaged. 
Immunohistochemistry – PERIOD2 DAB staining 
 DAB staining protocol used was a modified version from Karen Weis. Slices were washed 3 times 
with PBS. Slices were then quenched in 1% hydrogen peroxide (1%) for 30 min at room temperature. 
Slices were then washed 3 times with PBS. Slices were then blocked with 5% normal goat serum in PBS-
triton X (0.3%) for 1 h at room temperature. Slices were then incubated with primary PERIOD2 antibody 
(developed at the University of Illinois at Urbana-Champaign, at 1:25,000 dilution) in 3% normal goat 
serum and PBS-triton X for 48 h at 4˚C. Following primary antibody incubation, slices were washed 3 
times with PBS. Biotin conjugated secondary antibody (1:1,000) was then added for 1 h at room 
temperature in 3% normal goat serum and PBS-triton X. Following secondary antibody incubation, slices 
were washed 3 times with PBS. Slices were then incubated with ABC reagent mixture for 1 h at room 
temperature. Slices were then washed 3 times with PBS. Slices were then incubate with DAB reagent (1 
mM DAB, 240 mM NiSO4, 1% H2O2, and 185 mM NaOAc) for 10 min at room temperature. Tissue was 
then washed 3 times with PBS and mounted on microscope slides and allowed to dry. Once dried, slices 
were covered with Permount and a coverslip. Microscope slides were sealed with fingernail polish. 
Image acquisition 
All images were obtained using the same rigorous imaging techniques as discussed in Chapter 2. 
Images were obtained from the middle SCN, midway between the rostral and caudal tips, in the 
ventrolateral region. Researchers were also blinded to the condition and the time points for all brains 
analyzed.  
For PERIOD2-DAB imaging, brightfield illumination was used with a Nikon 4X objective 
microscope. For immunofluorescent intensity imaging was done with a Nikon 4X objective with a Texas 
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Red dichroic mirror. For GFAP reconstructions, images were acquired on a LSM510 Meta scanning 
confocal microscope (Zeiss Microscopy, Germany). To image GFAP, a 563 nm laser (30% laser power, 
850 master gain, -.1 digital offset) with a 40x oil immersion lens (1.4 NA) was used. Images were taken 
within the ventrolateral region of the middle SCN, rostral to caudal, immediately dorsal to the optic 
nerve. Three dimensional Z-stacks were taken with a vertical resolution of 0.5 µm. Upper and lower 
vertical limits of tissue imaging was set accordingly to the presence of signal during scanning mode. 
Analysis and statistics 
 Analysis and statistics were done as described previously in Chapter 2. For GFAP 
immunofluorescence at ZT2 and ZT14 a two-tailed Student’s t-test was used. At ZT/CT2 and 14 
comparison within the time point between experimental groups was done using one way ANOVA in 
Prism 6 (GraphPad). For GFAP branching complexity, branch terminal point values were logarithmically 
transformed to allow parametric statistical analysis with a mixed model ANOVA in SAS software. 
Significance was set at a 95 % confidence interval. 
3.4 Results  
PERIOD2-DAB staining results 
 Enucleated animals have intact SCN rhythms and will free run with a near 24-h period. However, 
each animal has a unique period and without activity monitoring equipment, animals may become 
misaligned to control groups. Short term enucleated animals were free running for only three days with 
little to no drift from estimated CT. To ensure that long term enucleated animals were analyzed with the 
correct control group, animals were stained for the core clock protein, PERIOD2. PERIOD2 protein 
concentration peaks at ZT 14 in the SCN and is at its minimum at ZT 2.[119,133] As expected, when control 
brains were stained for PER2, ZT 2 control brains had low PER2 and ZT 14 brains had high PER2 (Figure 
3.1). However, long term enucleated animals exhibited variation in the amount of PER2 staining in the 
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SCN, likely due to individual circadian rhythms that were greater or less than 24 h. Because of this, long 
term enucleated animals were grouped into either high or low PER2, instead of assigned a specific CT, 
and compared to the corresponding ZT controls. 
Fluorescence analysis of GFAP immunohistochemistry 
GFAP immunofluorescence was used as a measure of GFAP polymerization state. Previous 
studies have identified changes in the immunofluorescence at different times of day. The source of this 
change is still unknown but may report a change in GFAP state or protein level. GFAP standardized 
immunofluorescence intensity was significantly different between ZT 2 and ZT 14 (Figure 3.2B, p < 0.05, 
n =8). All experimental groups lost diurnal variation in GFAP immunostaining (Figure 3.2C-E). At CT 2 
both enucleated groups showed significantly lower GFAP immunostaining relative to control regions as 
compared to controls. Interestingly, animals at CT 2 kept in constant darkness did not have significantly 
lower GFAP immunostaining compared to controls (Figure 3.3A). GFAP immunostaining in experimental 
groups at CT 14 were all significantly lower compared to controls (Figure 3.3B). The loss of diurnal 
variation in GFAP immunostaining shows that the polymerization state of the astrocytic cytoskeleton in 
the SCN is regulated by light signals from the RHT. Previous work has shown that retinal input is required 
for proper development of GFAP in the rat SCN of the post-natal rat.[118] However, this loss of diurnal 
GFAP immunofluorescence intensity between enucleated groups of adult rats suggests a role for retinal 
input in the regulation of GFAP polymerization state in the adult rat SCN.  
GFAP branching reconstruction and analysis 
GFAP branch end points were used a measure of astrocyte complexity. GFAP does not contact 
the cell membrane but branches do support astrocyte projections. GFAP branch end points were not 
significantly different between control animals at ZT 2 and ZT 14. However, branch end points were 
49 
 
significantly different between controls and enucleated animals (3.4 A&B). We hypothesize that this 
significant reduction in branching is due to an overall decrease in expression of the GFAP cytoskeleton.  
GFAP diurnal polymerization changes are lost in constant darkness and short-term enucleated animals 
 To confirm results from imaging analysis of GFAP immunohistochemistry, we utilized a 
previously described method to separate soluble GFAP from polymerized GFAP (Chapter 2, page 37). 
Animals kept in constant darkness and short-term enucleated animals lost the observed diurnal shift in 
soluble GFAP as seen previously in control animals complimenting the GFAP immunostaining results 
(Figure 3.7A-C). The overall levels of GFAP were unchanged in DD animals compared to controls at both 
CT2 and CT14 (Figure 3.6A&B). Interestingly, rats enucleated for three days had significantly higher 
levels in overall GFAP at both CT2 and CT14 compared to control and DD groups but lost diurnal 
variation in soluble levels (Figure 3.6A&B, 3.7C). When comparing soluble to total GFAP at CT2, only 
short-term enucleated rats had significantly lower levels of soluble GFAP compared to controls (Figure 
3.8A). Intriguingly, significant differences were only observed between animals in constant darkness and 
short-term enucleated animals (Figure 3.8B).These results confirm that retinal input regulates the 
solubility state of GFAP in the SCN through an unidentified mechanism and that GFAP immunostaining 
and polymerization state are inversely correlated. 
3.5 Discussion 
The role of the retina in circadian rhythms has been extensively studied. Nearly all of these 
studies have focused on the neural component of RHT signaling despite the growing evidence of 
astrocytic regulation of synaptic and circuit behaviors within the brain. Retinal signaling is a regulator of 
astrocytic development and plasticity in post-natal rodents but the extent to which the retina can 
influence mature astrocytic plasticity is unclear. Our current study clearly demonstrates that the retina is 
the primary driver of the observed diurnal variation in GFAP cytoskeletal dynamics. Moreover, RHT 
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signaling is key for the relative increased levels of GFAP within the SCN compared to other local brain 
regions as previously observed. 
Enucleation with either short or long-term recovery significantly reduced the immunostaining of 
GFAP in the SCN at both ZT2 and ZT14 (Fig. 3.1). Constant darkness and both short and long-term 
enucleation also eliminated the diurnal difference between ZT2 and ZT14. This result suggests that 
diurnal differences observed in GFAP immunofluorescence is driven by an external signal and not driven 
by an autonomous astrocytic cell clock. Although GFAP was reduced in the enucleated SCN compared to 
control animals, the SCN immunofluorescence was still greater than the SPZ, demonstrating that SCN 
GFAP staining is still stronger in enucleated SCN tissue than in control regions of enucleated animals (Fig. 
3.1). Additional studies with animals kept in constant dark or enucleated for three days confirmed that 
the RHT signaling regulates GFAP immunostaining within the SCN. It is unclear whether this shift in 
polymerization state is driven directly by RHT signals onto astrocytes or indirectly via RHT signals onto 
SCN neurons. 
GFAP solubility state was significantly reduced in short-term enucleated animals compared to 
controls at CT2, likely due to a loss of RHT signaling, driving GFAP into insoluble filaments. Interestingly, 
at CT14 short-term enucleated animals were significantly lower compared to animals kept in constant 
darkness but not compared to controls. This result is likely due to slightly but not significantly higher 
levels of soluble GFAP in D:D animals from the loss of retinal signaling or possibly trophic signals from 
the eye in darkness due to the presence of an intact optic nerve. The resulting inflammation from 
enucleation likely drives GFAP into insoluble filaments through an unknown mechanism, creating the 
observed difference between CT14 D:D and short-term enucleated animals. We also observed 
significantly elevated levels of total GFAP in short-term enucleated animals compared to all other groups 
at both CT2 and CT14. We hypothesize that this observed increase is astrogliosis in response to the 
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damaged RHT post enucleation. Paradoxically, this increase in total GFAP was not observed in GFAP 
immunofluorescence.  
It is not understood how the RHT and the signals it carries to the circadian system regulate 
astrocytic GFAP. Moreover, the role of GFAP in astrocytic function is poorly understood within the SCN 
and the circadian system. Whether changes in GFAP immunoreactivity in enucleated animals are the 
result of an increase in degradation of GFAP remains unknown. One hypothesis is that signals from the 
RHT may play a role in the expression and maintenance of GFAP. RHT signals activate kinases known to 
phosphorylate GFAP.[95] GFAP, when phosphorylated, depolymerizes from filaments to soluble form of 
the protein.[70] Moreover, phosphorylation of GFAP appears protective from degradative 
mechanisms.[152] If RHT signals are phosphorylating GFAP in the presence of environmental light, then in 
the absence of RHT signals, GFAP would be dephosphorylated and subsequently degraded over time. 
Additionally, this diurnal dance of phosphorylation state may be responsible for the diurnal differences 
observed in GFAP immunoreactivity in intact animals. 
This study is the first to look at the effect of an intact optic nerve on adult astrocytic GFAP 
immunoreactivity in the rat SCN. The brain receives information from the optic nerve and processes 
time of day by the SCN. Astrocytes in the SCN express receptors and respond to these signals. However, 
previous studies have failed to agree on whether a diurnal GFAP fluctuation exists in the SCN. Moreover, 
to the researcher’s knowledge, no study has investigated the role of intact optic nerve signaling on the 
plasticity of the adult astrocyte cytoskeleton in the SCN. This comes as a surprise considering the 
potential role that diurnal astrocytic morphological plasticity plays in SCN physiology and the potential 
for astrocytes as targets for therapeutics. With the current data we hypothesize the model that retinal 
signals drive polymerization of the astrocyte cytoskeleton (Figure 3.8). Loss of the RHT results in a loss of 
signaling driving the GFAP cytoskeleton into the polymerized filamentous state. Since phosphorylation 
and depolymerization likely protects GFAP from degradation, the extended filamentous state results in 
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progressive degradation of GFAP as seen in the long term enucleated SCN brain slices. Moreover, if 
PACAP from the RHT drives the increased GFAP levels observed within the SCN, the loss of the RHT 
would also decrease overall GFAP from this perspective. 
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3.6 Figures 
Figure 3.1. To determine correct circadian time in long-enucleated animals, we performed DAB and 
GFAP staining in control and animals enucleated for at least 3 months. These long-enucleated animals 
were grouped into low (CT2) or high (CT14) Per2 groups. GFAP immunofluorescence was then compared 
to the correct control animals. 
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Figure 3.2. To compare the effects of constant darkness and enucleation on SCN astrocytes, we 
examined GFAP immunofluorescence in control, constant darkness, and both long-term and short-term 
enucleated animals. A) Representative GFAP staining from all experimental groups. B) Control animals 
had significantly higher GFAP immunostaining within the SCN at ZT14 compared to ZT2. Unpaired 
Student’s t-test. * p < 0.05. n = 8 animals per time point. C-E) Animals kept in constant darkness, short 
enucleated, and long enucleated lost the previously observed diurnal variation in GFAP 
immunofluorescence. Unpaired Student’s t-test for all treatment groups. DD treatment n = 5 animals 
per time point. sEnuc treatment n = 5 animals per time point. lEnuc treatment CT2 n = 9, CT14 n = 7.  
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Figure 3.3. GFAP immunofluorescence is decreased at ZT 2 and ZT 14 in the SCN of animals kept in 
constant darkness and in both short and long term enucleated animals. A) GFAP immunofluorescence at 
ZT/CT 2 was significantly lower in both sENUC and lENUC groups compared to controls animals and DD 
animals. One way ANOVA. * p < 0.05, *** p < 0.001, **** p< 0.0001. n = 6 animals per time point. B) 
GFAP immunofluorescence at ZT/CT 14 was significantly lower in DD, sENUC, and lENUC groups 
compared to control animals. One way ANOVA * p < 0.05, *** p< 0.001. n = 6 animals per time point.  
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Figure 3.4. Enucleation results in decreased branching complexity in the rat SCN. A. Average branch 
terminal points were reduced in enucleated rats when compared to controls at ZT 2, although not 
significant (n=5 for control, n=2 for enucleated; p>0.05). B) Average branch terminal points were 
reduced in enucleated rats when compared to controls at ZT 14, although not significant (n=5 for 
control, n=4 for enucleated; p>0.06). C) Representative images of SCN GFAP reconstructions at ZT 2 for 
control (left) and enucleated (right) animals. D) Representative images of SCN GFAP reconstructions at 
ZT 14 for control (left) and enucleated (right). Size bar = 50 µm. 
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Figure 3.5. Total GAPDH is not significantly different at ZT 2 and ZT 14. A) Mean signal intensity of 
GAPDH at ZT 2 in control animals and CT2 in DD and short enucleated animals was not significantly 
different between treatment groups. One way ANOVA. n = 6 animals per time point. B) Mean signal 
intensity of GAPDH at ZT 14 in control animals and CT 2 in constant dark and short enucleated animals 
was not significantly different between treatment groups. One way ANOVA. n = 6 animals per time 
point. 
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Figure 3.6. Total GFAP is increased in short enucleated animals at both ZT2 and ZT14. A) Total GFAP was 
significantly elevated in short enucleated animals. One way ANOVA. * p < 0.05, ** p <0.01. n = 6 animals 
per time point. B) Total GFAP was elevated in short enucleated animals compared to controls and DD 
animals. One way ANOVA. ** p < 0.01. n = 6 animals per time point.  
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Figure 3.7. Soluble GFAP levels are different between ZT 2 and ZT 14 in control animals but is lost in 
constant darkness or in short-term enucleteated animals. A.) Soluble GFAP levels are significantly 
different in animals kept on a 12-h:12-h light-dark cycle. Unpaired Student’s t-test. p < 0.05. B.) Animals 
kept in constant darkness for 3 days failed to exhibit significantly different soluble GFAP levels. Unpaired 
Student’s t-test. p > 0.05. C.) Animals enucleated and allowed to recover for 3-days also failed to show 
significantly different soluble GFAP levels. Unpaired Student’s t-test. p > 0.05. n = 6 animals for all time 
points and treatments.  
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Figure 3.8. GFAP solubility is altered in enucleated animals. A) Analysis of the ratio of soluble to total 
GFAP at ZT2 in controls and CT2 in DD and short enucleated rats. Analysis shows that DD solubility is not 
significantly reduced compared to controls however short enucleated rats have significantly lower 
soluble GFAP. One way ANOVA. * p < 0.05. n = 6 animals per time point. B) Analysis of the ratio of 
soluble to total GFAP at ZT14 and CT14 in DD and short enucleated rats. Analysis shows that both DD 
and short enucleated rats do not have significantly different soluble GFAP compared to controls. 
Comparison between constant dark and enucleated rats was significantly lower. One way ANOVA. * p < 
0.05. n = 6 animals per time point. 
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Figure 3.9. Optic nerve innervation and signaling to the SCN plays a role in astrocytic diurnal GFAP 
plasticity. A) Normal RHT innervation in the adult rat SCN results in diurnal differences between night 
and day GFAP filament polymerization. B) Enucleation eliminates RHT signals that normally drive GFAP 
plasticity.  
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CHAPTER FOUR 
 
INVESTIGATING ASTROCYTIC CYTOSKELETAL POLYMERIZATION STATE WITHIN 
THE ACUTE SCN BRAIN SLICE 
4.1 Abstract 
 Evidence suggests that light signaling from the RHT to the SCN influences the astrocyte 
cytoskeleton and subsequently their morphology.[81-83] Moreover, astrocytes within the retinorecipient 
area of the SCN show circadian variation of GFAP and fine perisynaptic astrocytic process (PAP) 
intercalation between neurons.[8,43] Axons within the RHT release glutamate in response to light 
signaling and may release PACAP concomitantly onto the SCN.[25,54,55] Intriguingly, SCN astrocytes 
express receptors and respond to PACAP from the RHT.[46,95]  Additionally, astrocytes express glutamate 
receptors and glutamate transporters, making them not only targets of glutamatergic signaling but also 
potentially responsible for clearance of excitotoxic levels of glutamate in the SCN.[161] We have 
previously shown that the astrocytic cytoskeletal protein GFAP polymerization state differs between 
early day and early night. Here we have utilized the acute SCN brain slice to determine whether the 
polymerization state of GFAP is regulated by the retinal signals glutamate and PACAP. Our results show 
that the GFAP state within the brain slice loses the diurnal variation observed in the intact animal within 
two hours in the slice environment. Moreover, the pharmacological treatments with glutamate and 
PACAP failed to elicit a significant response in solubility of the GFAP cytoskeleton as hypothesized. 
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4.2 Introduction 
 The RHT plays an important role in the development of the SCN. If the optic nerve is removed by 
enucleation in postnatal animals, astrocyte proliferation and development fail to occur in the SCN.[118] 
However, the importance of the optic nerve and the role that the RHT’s signal plays in adult astrocyte 
plasticity is not understood. The RHT releases glutamate onto the SCN in response to retinal 
stimulation.[22] Normally, constant levels of glutamate is excitotoxic to neurons. However, the SCN is well 
known to be resistant to glutamate levels that are excitotoxic in many other tissues.[17] The source of this 
protection is unknown but the local astrocytes are likely to play some role. Astrocytes exhibit 
neuroprotective qualities through the uptake of glutamate by Na+ dependent glutamate transporters, by 
releasing neuroprotective gliotransmitters, and by changing their shape to modulate synapses and the 
extracellular space.[11,52,161] Moreover, a recent study has shown that the astrocytes within the 
dorsomedial region of the SCN are key regulators of inhibitory signaling within the SCN during the 
subjective night. Intriguingly, astrocytic regional heterogeneity within the SCN and the potential 
physiological roles of these cells is a critical question for circadian biology. 
The role of glutamate, often considered the signal of light, has been well established by the 
Gillette laboratory in circadian biology.[29,30,40,41] Ding et al. showed that the circadian rhythm of SCN 
neuronal firing rate is non-responsive to glutamate signaling during the day, only shifting neuronal 
rhythms when glutamate from the RHT is released on the SCN during the subjective night.[30] The Gillette 
laboratory then went on to establish neuronal signaling cascades responsible for phase-shifting the peak 
activity in the SCN.[29] However, the role of glutamate in SCN astrocytes within the retinorecipient area 
in vivo has not been well studied. Astrocytes express glutamate transporters, metabotropic glutamate 
receptors, and ionotropic glutamate receptors, making it likely that they not only clear glutamate but 
also actively respond to glutamatergic signaling.[3,80,139] Whether or not glutamate can induce structural 
plasticity of astrocytes within the SCN, similar to the hippocampus, is unknown.[10]  
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The other signal from the RHT released within the SCN is PACAP.[25,55] PACAP is a well-known 
neuroprotective and neurodevelopmental signal in addition to modulating photic input to the SCN.[25] 
PACAP is structurally very similar and exhibits similar binding affinities to receptors of other known 
neuropeptides of the circadian clock.[59,95] PACAP binds to PAC1 and PAC2 receptors as well as VIP 
receptors VPAC1 and VPAC2, although affinities are notably different from VIP.[58] SCN astrocytes 
express receptors to both peptides. The functional relevance of astrocytic PACAP signaling has been 
hinted at by a study where PACAP induced stellation of cultured SCN astrocytes while glutamate did 
not.[68] The mechanism by which stellation of cultured astrocytes occurs is largely unknown however it is 
likely GFAP phosphorylation and cytoskeleton rearrangement is crucial. The PAC receptors are G-protein 
coupled receptor that increase intracellular cyclic AMP (cAMP), diacylglycerol, and inositol triphosphate 
(IP3).[94,95] These second messengers induce a plethora of cellular and transcriptional changes including 
activation of the kinases PKA and PKC. Both of this kinases have been shown to phosphorylate GFAP, 
resulting in depolymerization or structural reorganization.[60,70] If this holds true for SCN astrocytes in 
vivo, the hypothesis that SCN astrocyte cytoskeletal complexity is more dynamic during the day due to 
tonic RHT release of PACAP naturally follows. Whether the activity of PACAP is influenced by the co-
release of glutamate by the RHT during the day is unknown. PACAP can influence light induced phase 
shifts in the subjective night of rodents, so there is evidence of crosstalk between the two signaling 
mechanisms.[7,25,41] 
Both PACAP and glutamate bind to receptors that increase second messengers known to 
activate kinases that phosphorylate GFAP. Moreover, phosphorylation of GFAP regulates filament 
polymerization and degradation. PACAP increases intracellular cAMP and diacyl glycerol (DAG). These 
cofactors bind to and activate cAMP dependent kinase A (PKA) and DAG dependent kinase C (PKC). 
When activated, PKA and PKC can phosphorylate sites within the N-terminus of GFAP filaments. 
Metabotropic glutamate receptors 3 and 5 (mGluR3 and mGluR5) result in increased cAMP and DAG, 
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respectively. Taken together, synaptic signaling from the RHT in the form of PACAP and glutamate can 
induce phosphorylation of GFAP through second messenger signaling. The phosphorylation of GFAP 
results in depolymerization and a shift from the filamentous form of GFAP to a soluble, monomeric 
form. This dynamic phosphorylation and structural reorganization of a well-known, astrocytic 
cytoskeletal protein could directly translate to changes in glial-neuron interactions and communication. 
Our current study focused on the regulation of GFAP structural plasticity by released RHT signals 
in the acute SCN brain slice. Slice treatements of vehicle, glutamate, PACAP, or glutamate and PACAP 
were administered to the SCN slice at either ZT 2 or ZT 14. Our study found that the observed diurnal 
variation in GFAP polymerization state previously observed was lost within two hours in slice culture and 
that the pharmacological treatments failed to drive GFAP into the soluble state. 
4.3 Materials and methods 
Animals 
All animal experiments were conducted according to IACUC approved protocols. Long Evans 
(LE/BluGill) rats were sacrificed immediately after lights were turned on (ZT0) and immediately before 
lights were turned off (ZT12). This way brain slices were kept in the microenvironment chamber for 
approximately the same amount of time. To avoid potential shifts to the SCN clock, animals were rapidly 
sacrificed by guillotine decapitation without anesthetic.  
Tissue preparation and acute slice treatments 
 After brains were removed, the hypothalamus was isolated, and 500 µm thick coronal SCN slices 
were obtained by tissue chopper. Acute tissue slices were kept alive in controlled microenvironment 
chambers through constant perfusion of Hank’s buffered salt solution (HBSS) and glucose. Control slices 
were mock treated for 10 min with vehicle. To address the role of retinal signals on astrocyte GFAP 
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state, SCN slices were treated with either a 20µm drop of glutamate, 20µm drop of PACAP, or a 
treatment drop containing both glutamate and PACAP. 
Treatments were administered for 10 min starting at CT 2 or CT 14 in a static bath. Following 
treatment, tissue was flash frozen on dry ice. Flash frozen tissue was treated as described previously 
(Chapter 2). 
4.4 Results 
Characterization of the acute SCN brain slice 
 To determine the state of the astrocytic cytoskeleton within the acute SCN slice, Western blot 
analysis was conducted on acute SCN brain slices made while room lights were still on at either ZT0 for 
treatments at CT2 or ZT12 for treatments at CT14 (Figure 4.1A). GAPDH levels were not significantly 
different between treatments and time points (Figure 4.1C). Total GFAP levels were not significantly 
different between treatments and time points as well, however CT2 controls and glutamate, and CT14 
glutamate and PACAP all trended towards higher levels of total GFAP (Figure 4.1D). Unexpectedly, 
control SCN slices lacked the significant differences previously observed where ZT2 SCN slices had higher 
levels of soluble GFAP compared to ZT14 (Figure 4.2A). This result suggests that within two hours within 
the culture chamber the SCN brain slice appears similar to enucleated animal’s SCN tissue. 
RHT signals fail to drive depolymerization of the GFAP cytoskeleton 
 To assess whether RHT signals drive filamentous GFAP into the soluble form glutamate and 
PACAP were administered to the acute SCN brain slice. At either CT2 or CT14 glutamate, PACAP, or 
glutamate and PACAP together failed to elicit depolymerization of the GFAP within the SCN slice (Figure 
4.3A&B). Although not significant for either time of day or treatment, all manipulations at CT14 trended 
toward less soluble GFAP (4.3B). This was unexpected since we hypothesized that RHT signals drive the 
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previously observed diurnal changes in the intact rat at ZT2 and 14. These results taken with the 
observation that control slices lack the expected diurnal variation in GFAP solubility suggest that the 
acute SCN slice is not the optimal system to study the role of the RHT in SCN astrocytic cytoskeletal 
plasticity. 
4.5 Discussion 
 GFAP structural organization is regulated by phosphorylation of the head domain within GFAP 
monomers, where phosphorylated GFAP dissociates into soluble GFAP. The RHT synaptic signals PACAP 
and glutamate are known to increase the intracellular second messengers, cAMP and DAG. Moreover, 
cAMP and DAG are co-activators of PKA and PKC, both of which are kinases that are known to 
phosphorylate GFAP (Figure 4.2). Therefore, if PACAP and glutamate are released by the RHT during the 
day, increasing GFAP phosphorylation and decreasing GFAP filament formation, then GFAP 
immunoreactivity and branching complexity will be lower during the subjective day relative to subjective 
night. Additionally, if RHT signals are administered to an acute brain slice preparation of the SCN, one 
may predict that GFAP will become phosphorylated and depolymerize. If administered during the 
subjective night, RHT signals could potentially increase GFAP phosphorylation, resulting in significant 
immunoreactivity and average astrocyte GFAP branching complexity reductions, relative to controls. 
Whether one would see a reduction in GFAP immunoreactivity and branching during the subjective day 
is not entirely predictable, considering there is constitutive RHT signaling during the day. 
 The SCN brain slice has been extensively characterized in regards to neuronal function. 
Unfortunately, very little is known about the how the astrocytes within SCN behave ex vivo. In tissue 
culture where the brain is sliced, astrocytic scarring appears rapidly. However, multiple imaging 
techniques on the brain slice culture have shown that astrocytes still function. Additionally, a recent 
study focused on astrocytes within the SCN showed that astrocytes in the dorsomedial or “shell” region 
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of the SCN still exhibit calcium oscillations in the organotypic slice. Unfortunately, the localization of the 
previously observed GFAP cytoskeletal dynamics is unknown. 
 The understanding of signaling mechanisms that regulate astrocytic cytoskeletal dynamics is a 
powerful tool in neurobiology. Astrocytes regulate the blood-brain barrier, clear the brain of metabolites 
during sleep, participate in synaptic signaling, and play pivotal roles in brain immunological function. 
Identifying a circadian mechanism for this regulation may translate to clinical application through 
identification of temporal windows for drug delivery to the brain, increasing memory and learning, 
regulating sleep patterns, and helping clinicians determine better treatment regimens. Unfortunately, 
the acute SCN slice model utilized here is likely not the best method for studying the role of RHT 
signaling on astrocyte cytoskeletal plasticity. 
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4.6 Figures 
Figure 4.1. Characterization of soluble GFAP within the acute SCN slice. A) Schematic illustrating the 
experimental design of acute SCN slice culture. SCN slices were made at ZT0/12 and allowed to recover 
for 2 h. At CT2/14 slices were treated for 10 min in a standing bath. After treatment, tissue was flash 
frozen and analyzed using techniques described. B) Western blots of supernatant and total GFAP 
samples with controls and treatments at both CT2 and CT14. C) GAPDH is not significantly different as 
measured by Western blot probed with α-GAPDH antibody. Two way ANOVA. p > 0.05 n= 4 samples per 
time point. D) Total GFAP was not significantly different between time points and treatments. Two way 
ANOVA. p > 0.05 n= 4 samples per time point. 
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Figure 4.2. Solubility of GFAP is not significantly different within treatments at CT2 and CT14. A-D) 
Solubility of GFAP is not significantly different at CT2 compared to CT14 in control, glutamate treated, 
PACAP treated, or glutamate + PACAP treated acute SCN slices. Unpaired Student’s t-test for all groups. 
p > 0.05 for all groups. n = 4 samples per treatment and per time point.  
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Figure 4.3. GFAP solubility is not significantly different between treatments at CT2 and CT14. A) 
Solubility of GFAP at CT2 was not significantly different between controls and all treatment groups. One 
way ANOVA. p > 0.05. n = 4 samples per treatment. B) Solubility of GFAP at CT14 was not significantly 
different between controls and all treatment groups. One way ANOVA. p > 0.05. n = 4 samples per 
treatment. 
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CHAPTER FIVE 
 
DISCUSSION AND CONCLUSIONS 
 
5.1 Abstract 
  
Astrocytes are emerging as pivotal regulators of synaptic signaling and circuit activity. Research 
has shown that astrocytes can participate in brain activity through clearance of synaptic signals such as 
glutamate or GABA, regulation of ions critical for neuronal excitability, release of neuroactive signals 
known as gliotransmitters, and through morophological plasticity.[104] Despite the increasing focus on 
astrocytes in neurophysiology, morphological plasticity and the potential extent it plays in astrocyte 
function is poorly understood. Astrocytic perisynaptic endfeet change shape with neuronal activity 
within the hippocampus, strengthening or weakening the signal as the astrocyte moves closer or further 
away from the synapse.[10] Moreover, a single astrocyte can ensheath up to 10,000 synapses, all of which 
may be regulated through morphological movement independent of the others, suggesting an amazing 
level of complexity and regulation through astrocytic shape changes.[121] 
Despite this attractive new field of study, we have yet to understand how astrocyte movement 
is actualized. Morphological plasticity is facilitated through changes in the astrocyte’s cytoskeleton of 
which GFAP is a key intermediate filament. In addition to playing a role in overall structural stability of 
astrocytes, GFAP has been implicated in movement of glutamate transporters to the cell surface, and as 
an inflammatory marker. Moreover, studies have illustrated the marked astrocytic heterogeneity 
throughout the CNS, suggesting a wide variety of roles astrocytes may play. 
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5.2 Diurnal variation in GFAP state within the adult rat SCN 
 It was previously unknown whether GFAP changes between day and night or in a circadian 
fashion within the adult male rat SCN. Different animal models and study methods have shown 
conflicting results.[82,86,118] In my first aim I showed a shift in the complexity within the astrocyte 
population’s GFAP cytoskeleton between day and night, where more cells have fewer branches in the 
early day compared to early night. We then showed that the overall GFAP immunostaining of the rat 
SCN is lower in the early day compared to early night. Lastly, we have shown that GFAP can be found in 
the soluble fraction of SCN punch lysates. Moreover, we have shown that there is significantly more 
GFAP in the soluble state in the early day compared to the early night. This suggests that the GFAP 
cytoskeleton is less polymerized in early day compared to early night, corroborating our previous 
observations in both branching complexity and overall immunostaining intensity of GFAP in the SCN. 
 There are two primary hypotheses that arise from the observed differences in GFAP state 
between early day and early night. The first states that there is circadian regulation at the level of the 
SCN or even individual cells, driven by the cell clock that regulates the polymerization state of the GFAP 
cytoskeleton. If this were the case, then this change in GFAP state should be observable in the absence 
of external signaling. The second hypothesis states that the observed shift in GFAP is driven by retinal 
signaling. The SCN receives significant retinal input in the form of glutamate and PACAP. Astrocytes 
express receptors to both of these signals. Moreover, the secondary messengers associated with these 
receptors activate PKA, PKC, and CaMKII all of which have been shown to phosphorylate GFAP.[61,69] 
GFAP phosphorylation depolymerizes filaments into monomers. If this hypothesis were correct then the 
observed shift in GFAP state would cease in the absence of retinal signaling. 
 There are three key experiments that still need to be completed to capitalize on these 
observations. First, it needs to be shown that the shift in GFAP into the soluble fraction is regulated by a 
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phosphorylation event. There are commercial antibodies against phosphorylated forms of GFAP. There 
are 4 serine residues and one tyrosine residue that are potential phosphorylation sites all of which are 
putative regulators of polymerization of GFAP filaments. A screen of soluble fractions of GFAP samples 
by the various antibodies could rapidly show which site is phosphorylated. Additionally, some GFAP 
residues are phosphorylated by a limited number of putative kinases, which could aid in the focus on 
signaling mechanisms. Second, the GFAP cytoskeleton represents a limited fraction of the total 
astrocyte. It needs to be clearly demonstrated to what extent the GFAP cytoskeleton associates with the 
cell membrane. In the hippocampus researchers have shown that the GFAP cytoskeleton represents 
roughly thirteen percent of the total cell volume while failing to extend into the fine perisynaptic 
astrocytic processes that surround the tripartite synapse.[21] It should be noted however that the SCN 
astrocyte is morphologically different than a hippocampal astrocyte. These differences suggest a variant 
relationship between the SCN astrocyte’s cytoskeleton and the cell membrane. Lastly, the use of 
emerging technology in the objective measurement of immune-based studies need to be validated. In 
our study we utilized the neural reconstructive software Imarus to recreate the GFAP cytoskeleton and 
measure branch terminal points as a mark of cellular complexity. This experiment from the very 
beginning is flawed. Absolute reconstructions of immunostaining based analyses potentially suffer from 
transitive error, meaning that an error during the steps of sample acquisition and analysis will be 
compounded by further steps in analysis. Variance in staining, image acquisition, and image analysis can 
change the observed number of GFAP branches dramatically. Without a standard to compare to, such as 
a control region of the brain, changes in branching complexity due to experimental error could be 
virtually undetected. For this very reason, we utilized staining controls in our additional immunostaining 
experimental procedures to confirm that the observed variance was due to an actual change in the 
GFAP polymerization state rather than experimental error. 
5.3 Retinal regulation of GFAP state within the rat SCN 
75 
 
 The greatest environmental signal that an organism utilizes to assess time-of-day is the presence 
or absence of environmental light. The retina sends photic information to the occipital lobe for visual 
processing but also contains specialized cells that send light information to the SCN, the intrinsically 
photosensitive retinal ganglion cells. This retinal input is the largest afferent signal that the SCN receives 
and light information is passed to SCN neurons in the form of the excitatory amino acid glutamate and 
the peptide PACAP.[25,55] These signals fail to initiate a response during the subjective day in the SCN but 
can shift firing rhythms earlier or later, depending on when the signal is received. The extent to which 
astrocytes within the SCN respond to these signals is unknown but their role in retinal signal is suggested 
by the fact the regions of the brain that receive these signals express higher levels of GFAP relative to 
other brain regions. 
 In my first aim I showed that astrocytes exhibit diurnal variation in GFAP state between early 
day and early night, where early day had higher levels of soluble GFAP. To test whether this observation 
is dependent on the presence of environmental light signals or is maintained in a circadian manner, 
animals were kept in constant darkness. Animals kept in constant darkness lost the diurnal variance in 
GFAP solubility state and immunostaining of the SCN. To determine the importance of an intact retina 
on GFAP levels within the SCN, we enucleated animals for both short (3 days) or long (3 months) term 
durations. Short-term enucleated animals lost fluctuations in both solubility state of GFAP as well as 
immunofluorescence, similar to animals kept in constant darkness. Interestingly, short-term enucleated 
animals exhibited greatly increased levels of GFAP relative to controls and animals kept in constant 
darkness. Long-term enucleated animals lost diurnal variations in GFAP and also appeared to have 
significantly lowered GFAP compared to control regions of the hypothalamus. Moreover, long term 
enucleated animals had significantly atrophied optic nerves. Unfortunately, there were no samples 
available from long term enucleated animals for Western blot analysis. Taken together, these results 
show that variation in GFAP state is regulated by retinal signaling either directly through ipRGC signals 
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directly at receptors on astrocytes or indirectly through SCN neuronal signals released in response to 
retinal signaling. Enucleation results in increased levels of GFAP, like due to an inflammatory response to 
RHT damage. 
 In order to complete this study, Western blot analysis needs to be conducted on long term 
enucleated SCN tissue. This experiment should show to what extent an intact retina regulates the 
observed increase in levels of SCN GFAP compared to other brain regions. PACAP is an established driver 
of GFAP expression in the developing cortex. The SCN can be identified from other hypothalamic nuclei 
based on the elevated basal expression of GFAP and PACAP localized to the RHT synapse. Despite this 
information we still haven’t definitively shown that PACAP is driving the elevated GFAP expression in the 
SCN. Moreover, what physiological benefit does elevated GFAP expression bestow on the SCN? Lastly, it 
is still unclear whether astrocytes respond directly to retinal signals (glutamate and PACAP) or indirectly 
through SCN signals released in response to retinal input. 
5.4 Retinal signals regulate GFAP state in the SCN brain slice 
 The retinohypothalamic tract (RHT) projects from the retina to the SCN of the hypothalamus. 
The presence of environmental light is transmitted to SCN neurons from ipRGCs primarily in the form of 
glutamate and to a lesser extent, PACAP. Glutamate signaling has been characterized within the SCN 
where it elicits phase advances or delays during the night (depending on when the signal is given) while 
having no effect during the day. PACAP plays more of a modulatory role of glutamatergic responses in 
the SCN during the night while invoking a phase shift if administered during the day. Both glutamate and 
PACAP can be found within the ipRGC pre-synaptic bouton, suggesting that both are released in 
response to light hitting the retina. In the first two aims of my thesis I have shown that diurnal variances 
of GFAP state exist between early day and early night and that this variance is dependent on retinal 
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signals. In my second aim, I identified light signaling and the presence of an intact optic nerve as key 
regulators of diurnal GFAP cytoskeleton plasticity. 
In chapter 4 we originally intended to study which signals from the optic nerve could shift GFAP 
polymerization state. To study how SCN astrocyte GFAP state is regulated by retinal signals, we utilized 
the acute SCN slice model to directly treat SCN astrocytes with glutamate and PACAP. Unexpectedly, we 
found that SCN astrocytes within control slices lose their diurnal variation in GFAP solubility within two 
hours. This result suggests that the acute tissue slice is in a state that may or may not represent the 
intact signaling observed in chapters 2 and 3. These results were frustrating considering the significant 
body of literature showing the SCN continues to oscillate within the culture chamber. Moreover, 
Brancacchio et al. recently showed that astrocytic calcium signaling in the “shell” region of the SCN also 
express circadian calcium fluctuations in organotypic culture. Despite the ability of the SCN brain slice to 
maintain neuronal and transcriptional circadian rhythms, our results suggest that the GFAP cytoskeleton 
and likely astrocyte morphology rhythms are not intrinsic and require external stimuli, namely light, to 
maintain the previously observed rhythm. Our original thrust was to study how retinal signals would 
drive GFAP into the soluble or filamentous state. At both time points, results were not significant with 
the four repeats although there seems to be a strong trend towards less soluble GFAP in the early night 
with treatment of glutamate, PACAP, or both. Future experiments need to be conducted to ascertain the 
effect of creating the brain slice on the state of astrocytes and the GFAP cytoskeleton. Once the 
astrocytes within the slice have been characterized, we can begin to manipulate astrocytic receptors and 
intracellular signals in response to glutamate and PACAP to determine the mechanism of GFAP 
polymerization state regulation. 
In conclusion, the work within this thesis clearly shows that there are diurnal shifts in GFAP state 
between early day and early night. First, we showed that the GFAP cytoskeleton of individual astrocytes 
can be reconstructed while variability between astrocytes make computer-based reconstructions a 
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difficult method to reproduce. However, the extent of morphological heterogeneity, even within the 
same brain region may have physiological significance. Second, we show that the observed changes in 
GFAP are likely due to a shift in GFAP polymerization state and not as a result of fluctuations in total 
GFAP. Third, we clearly establish that this cytoskeletal dynamic is the result of RHT signaling and not a 
cell clock phenomenon. Lastly, in order to identify the regulator of SCN astrocyte cytoskeletal dynamics 
we unexpectedly establish that the brain slice culture is not a good model for this analysis. Clearly, work 
still needs to be conducted to flush out the physiological importance of astrocytic morphological 
dynamics within the SCN. As it stands, we propose the following model describing our current 
understanding of how retinal signals regulate diurnal astrocytic morphological dynamics within the adult 
male SCN. 
  
79 
 
5.5 Figures 
 
Figure 5.1. Proposed mechanism for GFAP changes in response to light signaling. RHT cells release 
PACAP and glutamate onto the SCN, which signals to both neurons and astrocytes. Astrocytes express 
receptors to both signals, which increase the intracellular second messengers cAMP, DAG, and Ca2+. 
These second messengers activate kinases known to phosphorylate GFAP (PKA, PKC, and CaMKII). These 
kinases phosphorylate GFAP, which depolymerizes the filaments and protects the protein from 
degradation. During the night, when light signals are absent from the SCN, an unknown phosphatase 
(hypothesized protein phosphatase 1) dephosphorlylates GFAP, allowing for repolymerization. Thus, 
light signaling is proposed to create the diurnal differences observed in GFAP complexity between day 
and night as well as the significant decrease in GFAP complexity and overall protein levels in the SCN in 
enucleated animals. 
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